Citation	Subject	Subject Label	Non grounded Subject	Potential MAXO	Predicate	Object	Object Label	Non grounded Object	Potential HP	Qualifier	Qualifier Label	Non grounded Qualifier	Potential MONDO	Subject Qualifier	Subject Extension	Object Extension	Count
29193273			identification of therapeutic targets	[]	treats			overstimulation of n-methyl d-aspartate receptors	[]			nmdar-mediated excitotoxicity	[('MONDO:0011603', 'NM'), ('MONDO:0018958', 'NM')]		therapeutic targets	n-methyl d-aspartate receptors	1
29193273			identification of therapeutic targets	[]	prevents			neuronal death	[]			nmdar-mediated excitotoxicity	[('MONDO:0011603', 'NM'), ('MONDO:0018958', 'NM')]				1
30549309			monitoring premanifest subjects	[]	treats			shorter telomeres	[]	mondo:0007739	huntington's disease		[]				1
30549309			monitoring premanifest subjects	[]	treats			significant increase of pgamma-h2ax	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		pgamma-h2ax		1
30549309			finding	[]	treats			shorter telomeres	[]	mondo:0007739	huntington's disease		[]		patient-specific drugs		1
30549309			finding	[]	treats			significant increase of pgamma-h2ax	[]	mondo:0007739	huntington's disease		[]		patient-specific drugs		1
29476441			nutritional intervention	[('MAXO:0000009', 'nutritional intervention')]	prevents			lower body mass index	[('HP:0500001', 'BO')]	mondo:0007182	spinocerebellar ataxia type 3 (sca3)		[]	to promote weight gain	nutritional intervention		1
29476441	maxo:0000009	nutritional intervention		[]	prevents			severity of ataxia	[('HP:0001251', 'Ataxia'), ('HP:0012824', 'Severity')]	mondo:0007182	spinocerebellar ataxia type 3 (sca3)		[]	to promote weight gain	nutritional intervention		1
30618191			use of resting-state fmri	[('MAXO:0001000', 'fMRI')]	treats			decreased connectivity between the putamen and medial prefrontal cortex	[]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"	in the study	resting-state fmri		1
30618191			application of group independent component analysis	[]	treats			significant association between disease burden and connectivity in various brain regions	[]	mondo:0007739	huntington's disease		[]	in the study			1
30618191			application	[]	treats			decreased connectivity between the putamen and medial prefrontal cortex	[]	mondo:0007739	huntington's disease		[]	in the study	k-means clustering algorithm		1
34077591			fiberoptic endoscopic evaluation of swallowing (fees)	[]	treats			compromised swallowing safety	[]	mondo:0007739	huntington disease		[]				1
34077591			high-resolution anatomical magnetic resonance imaging (mri)	[]	treats			compromised swallowing safety	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]	high-resolution	anatomical magnetic resonance imaging	n/a	1
30635944			purkinje cell loss	[]	treats			motor symptoms	[]	mondo:0007739	huntington's disease		[]				1
30685323			therapy	[('MAXO:0001298', 'therapy')]	treats			progressive motor dysfunction	[('HP:0003676', 'Progressive')]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"		stem cell-based		1
30685323	maxo:0001298	therapy		[]	treats	hp:0001268	cognitive decline		[]	mondo:0007739	huntington's disease		[]		stem cell-based		1
30685323			stem cell-based therapy	[('MAXO:0001298', 'therapy')]	treats	hp:0000708	behavioral symptoms		[]	mondo:0007739	huntington's disease		[]				1
35618981	maxo:0000647	chemotherapy		[]	treats	hp:0012174	glioblastoma		[]	mondo:0005071	neurological disorders		[]				1
35618981			combination anti-retro viral therapy	[('MAXO:0001298', 'therapy')]	treats			neurological disorders	[]	mondo:0005109	hiv		[]	with chemical	anti-retro viral therapy		1
35618981			use of anti-alzheimer drugs	[]	treats	hp:0100543	cognitive impairment		[]	mondo:0005071	neurological disorders		[]		anti-alzheimer drugs		1
35618981			brain targeted drug delivery	[]	prevents			cns toxicity	[]	mondo:0005071	neurological disorders		[]	using nanodiamonds	nanodiamonds		1
34697770			enhanced delivery	[]	prevents			generation of reactive oxygen species (ros)	[]	mondo:0005559	neurodegenerative diseases		[]		natural products		1
34697770			enhanced delivery	[]	treats			accumulation affects cell metabolism	[]	mondo:0005559	neurodegenerative diseases		[]		natural products		1
34697770			nanoformulations	[]	treats			neurodegenerative diseases	[('HP:0002180', 'Neurodegenerative disease')]				[]	with quercetin, curcumin, resveratrol, chrysin, piperine, ferulic acid, huperzine a, berberine, baicalein, hesperetin, retinoic acid	quercetin, curcumin, resveratrol, chrysin, piperine, ferulic acid, huperzine a, berberine, baicalein, hesperetin, retinoic acid		1
34697770			microneedles patches	[]	treats			neurodegenerative diseases	[('HP:0002180', 'Neurodegenerative disease')]				[]	with quercetin, curcumin, resveratrol, chrysin, piperine, ferulic acid, huperzine a, berberine, baicalein, hesperetin, retinoic acid	quercetin, curcumin, resveratrol, chrysin, piperine, ferulic acid, huperzine a, berberine, baicalein, hesperetin, retinoic acid		1
30849283			management of chorea	[]	treats			jerky involuntary movements	[('HP:0004305', 'Involuntary movements'), ('HP:0004305', 'Involuntary movements')]	mondo:0007739	huntington's disease		[]				1
30849283			management of chorea	[]	treats			interference with daily functioning	[]	mondo:0007739	huntington's disease		[]				1
30849283			management of chorea	[]	treats			impact on health-related quality of life	[]	mondo:0007739	huntington's disease		[]				1
31417253			administration	[]	treats			inflammation	[]	mondo:0002602	central nervous system disorders		[]		nano-curcumin		1
31417253			improved drug delivery	[]	prevents			neurological dysfunction	[]	mondo:0002602	central nervous system disorders		[]		chebi:50803		1
31417253			administration	[]	treats			inflammation	[]	mondo:0002602	central nervous system disorders		[]	with curcumin	nano-curcumin	curcumin	1
30262639			probabilistic diffusion-weighted mr imaging tractography	[]	treats			electrophysiologic abnormalities	[]	mondo:0005180	parkinson's disease		[]				1
30262639			probabilistic diffusion-weighted mr imaging tractography	[]	treats			electrophysiologic abnormalities	[]	mondo:0003441	dystonia		[]				1
30262639			probabilistic diffusion-weighted mr imaging tractography	[]	treats			electrophysiologic abnormalities	[]	mondo:0007739	huntington's disease		[]				1
30262639			programming the higher contacts	[]	treats			electrophysiologic abnormalities	[]	mondo:0005180	parkinson's disease		[]		pallidal deep brain stimulation	electrophysiologic abnormalities	1
30262639			programming the higher contacts in pallidal deep brain stimulation	[('MAXO:0000943', 'deep brain stimulation')]	treats			electrophysiologic abnormalities	[]	mondo:0003441	dystonia		[]				1
30262639			pallidal deep brain stimulation	[('MAXO:0000943', 'deep brain stimulation')]	treats			electrophysiologic abnormalities	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]	programming the higher contacts in			1
30327540			telephone screening	[]	prevents			referrals	[]			hypermobile ehlers-danlos syndrome	[('MONDO:0002254', 'hypermobile Ehlers-Danlos syndrome'), ('MONDO:0007523', 'syndrome')]				1
31552448			manipulation	[]	treats			misfolding and aggregation	[('HP:0001658', 'MI')]			polyglutamine diseases	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]		hsp70 and related co-chaperones	mutant proteins	1
31552448			development of small molecules	[]	treats			misfolding and aggregation of mutant proteins	[('HP:0001658', 'MI')]			polyglutamine diseases	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]	enhance	hsp70 activity		1
31907286	maxo:0000065	aerobic exercises		[]	treats			motor impairments	[]	mondo:0007739	huntington disease		[]				1
31907286			resistance training	[]	treats			motor impairments	[]	mondo:0007739	huntington disease		[]				1
31907286			supervised gait training	[]	treats			spatiotemporal features of gait	[]	mondo:0007739	huntington disease		[]				1
31907286			exercise training	[]	treats			balance	[]	mondo:0007739	huntington disease		[]				1
31907286			inspiratory and expiratory training	[]	treats			breathing function and capacity	[]	mondo:0007739	huntington disease		[]				1
31907286			training of transfers	[]	treats			performance in mid stages	[('HP:0001658', 'MI')]	mondo:0007739	huntington disease		[]				1
31907286			getting up from the floor	[]	treats			performance in mid stages	[('HP:0001658', 'MI')]	mondo:0007739	huntington disease		[]				1
31907286			aerobic exercise (alone or in combination with resistance training)	[('MAXO:0000065', 'aerobic exercise')]	treats			fitness	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]				1
31907286			aerobic exercise (alone or in combination with resistance training)	[('MAXO:0000065', 'aerobic exercise')]	treats			motor function	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]				1
34531262			small-animal pet imaging	[]	treats			synaptic dysfunction	[]	mondo:0007739	huntington disease		[]		11c-ucb-j		1
34531262			3h-ucb-j autoradiography	[]	treats			synaptic dysfunction	[]	mondo:0007739	huntington disease		[]		3h-ucb-j autoradiography		1
34531262			sv2a immunofluorescence	[]	treats			synaptic dysfunction	[]	mondo:0007739	huntington disease		[]		sv2a immunofluorescence		1
29663942			longitudinal anthropometric assessment	[]	treats			motor and cognitive impairment	[('HP:0100543', 'Cognitive impairment'), ('HP:0100543', 'Cognitive impairment')]	mondo:0007739	huntington's disease		[]				1
29663942			longitudinal anthropometric assessment	[]	treats			body measurement growth abnormalities	[('HP:0500001', 'BO')]	mondo:0007739	huntington's disease		[]				1
29663942			mixed-effect model analysis	[('MAXO:0000775', 'EFF')]	treats			progressive decline in cognitive behaviors	[('HP:0003676', 'Progressive')]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		mixed-effect model analysis		1
29663942			mixed-effect model analysis	[('MAXO:0000775', 'EFF')]	treats			motor impairment	[]	mondo:0007739	huntington's disease		[]				1
32250312			uniqure	[]	treats			huntington's disease	[]				[]		amt-130		1
32250312			neurocrine biosciences kinect-hd trials	[]	treats			huntington's disease	[]				[]		neurocrine biosciences kinect-hd trials		1
31725947			treatment to dampen t-cell-driven inflammation	[]	treats			immune abnormalities	[]	mondo:0007739	huntington disease		[]				1
31725947			treatment to dampen t-cell-driven inflammation	[]	treats			increased levels of proinflammatory cytokines, including il-17	[]	mondo:0007739	huntington disease		[]				1
31725947			treatment to dampen t-cell-driven inflammation	[]	treats			increased consumption of the lymphocyte growth factor il-7	[]	mondo:0007739	huntington disease		[]				1
31725947			treatment to dampen t-cell-driven inflammation	[]	treats			increased prevalence of il-17-producing th17.1 cells	[]	mondo:0007739	huntington disease		[]				1
31725947			treatment to dampen t-cell-driven inflammation	[]	treats			skewing in the balance between proinflammatory and regulatory t cells	[]	mondo:0007739	huntington disease		[]				1
35698434			physical activity	[]	treats			decreased walking endurance	[]	mondo:0007739	huntington disease		[]				1
35698434			physical activity	[]	treats			reduced lower limb functionality strength	[]	mondo:0007739	huntington disease		[]				1
35698434			physical activity	[]	treats			impaired cognition function	[]	mondo:0007739	huntington disease		[]				1
35698434	maxo:0000065	aerobic exercises		[]	prevents			impaired motor function	[]	mondo:0007739	huntington disease		[]				1
35698434	maxo:0000065	aerobic exercises		[]	prevents			reduced gait speed	[]	mondo:0007739	huntington disease		[]	implied, though no benefits found			1
35698434	maxo:0000065	aerobic exercises		[]	prevents			compromised activities of daily living (adl)	[]	mondo:0007739	huntington disease		[]				1
35698434	maxo:0000065	aerobic exercises		[]	prevents			poor balance	[]	mondo:0007739	huntington disease		[]				1
35698434			aerobic exercises	[('MAXO:0000065', 'aerobic exercise')]	prevents			limited mobility	[]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"				1
31093973			genetic testing	[('MAXO:0000127', 'genetic testing')]	prevents			knowledge of huntington disease gene status	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		genetic testing	knowledge of huntington disease gene status	1
31093973			developing treatments	[]	treats			symptoms	[]	mondo:0007739	huntington's disease		[]				1
34291654			utilization of palliative care	[('MAXO:0000021', 'palliative care')]	treats	hp:0000709	psychosis		[]	mondo:0007739	huntington disease		[]		palliative care		1
34291654			utilization of palliative care	[('MAXO:0000021', 'palliative care')]	treats	hp:0011951	aspiration pneumonia		[]	mondo:0007739	huntington disease		[]				1
34291654			utilization of palliative care	[('MAXO:0000021', 'palliative care')]	treats	hp:0000716	depression		[]	mondo:0007739	huntington disease		[]		palliative care		1
34291654			hospice services	[]	treats	hp:0000709	psychosis		[]	mondo:0007739	huntington disease		[]				1
34291654			hospice services	[]	treats	hp:0011951	aspiration pneumonia		[]	mondo:0007739	huntington disease		[]				1
34291654			hospice services	[]	treats	hp:0000716	depression		[]	mondo:0007739	huntington disease		[]				1
31467235			mr imaging (t1wi and dti)	[]	tracks			progressive thinning of the cerebral cortex	[('HP:0003676', 'Progressive')]	mondo:0007739	huntington's disease		[]				1
31467235			mr imaging (t1wi and dti)	[]	tracks			increasing diffusivity within the cerebral cortex	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		mr imaging (t1wi and dti)		1
38263475			diagnosis	[]	treats			retinal pathologies	[]			neurodegenerative diseases of the central nervous system	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]		oct biomarkers		1
38263475			prognosis	[]	treats			macular ganglion cell inner plexiform layer thickness abnormalities	[]			neurodegenerative diseases of the central nervous system	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]		oct biomarkers	macular ganglion cell inner plexiform layer thickness abnormalities	1
38263475			follow-up	[]	treats			peripapillary retinal nerve fiber layer thickness abnormalities	[]			neurodegenerative diseases of the central nervous system	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]		oct biomarkers		1
38263475			excluding retinal pathologies	[]	treats			retinal pathologies	[]			neurodegenerative diseases of the central nervous system	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]				1
30950323			application of the concept of total pain	[]	prevents			total pain	[('HP:0012531', 'Pain'), ('HP:0012531', 'Pain')]	mondo:0016621	juvenile huntington disease		[]				1
33856270			co-treatment	[]	treats			neurobehavioral alterations	[]	mondo:0007739	huntington disease		[]		chebi:50202		1
33856270			co-treatment	[]	treats			neuronal cell death	[]	mondo:0007739	huntington disease		[]		chebi:50202		1
33856270			increase in the monoamine oxidase activity	[]	treats			neurobehavioral alterations	[]	mondo:0007739	huntington disease		[]	with naringenin	chebi:50202		1
33856270			increase in serotonin levels	[]	treats			neurobehavioral alterations	[]	mondo:0007739	huntington disease		[]	with naringenin	chebi:50202		1
33856270			reduction of astrocytes activation	[]	treats			neurobehavioral alterations	[]	mondo:0007739	huntington disease		[]	with naringenin	chebi:50202		1
33856270			attenuation of neuronal cell death	[]	treats			neuronal cell death	[]	mondo:0007739	huntington disease		[]	with naringenin	chebi:50202		1
31712634			preimplantation genetic testing	[('MAXO:0000127', 'preimplantation genetic testing'), ('MAXO:0009003', 'genetic testing')]	prevents			huntington disease	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]	(pgt-m)	preimplantation genetic testing		1
31712634			whole genome amplification	[]	treats			diagnostic challenges	[]	mondo:0007739	huntington's disease		[]		whole genome amplification		1
31712634			triplet-primed pcr (tp-pcr) analysis	[]	treats			diagnostic challenges	[]	mondo:0007739	huntington's disease		[]				1
31712634			multi-microsatellite marker genotyping	[]	treats			diagnostic challenges	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		multi-microsatellite marker genotyping		1
31712634			embryo transfers	[]	prevents			neurodegenerative disorder	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]	with	unaffected embryos		1
31712634			amniocentesis	[]	confirms			embryo unaffected status	[('HP:0032321', 'Unaffected')]	mondo:0007739	huntington's disease		[]				1
35695745			supplementation	[]	treats			left-sided hemichoreatic movements	[('HP:0012835', 'Left-sided'), ('HP:0012835', 'Left')]	mondo:0020696	vitamin b12 deficiency		[]		chebi:176843		1
35695745			18 f-fdg pet/ct	[('MAXO:0000571', 'CT')]	treats (by diagnosis)			left-sided hemichoreatic movements	[('HP:0012835', 'Left-sided'), ('HP:0012835', 'Left')]	mondo:0020696	vitamin b12 deficiency		[]				1
35695745			mri of the brain	[('MAXO:0000427', 'MRI of the brain')]	treats			hemichoreatic movements	[]			vitamin b12 deficiency	[('MONDO:0020696', 'vitamin B12 deficiency'), ('MONDO:0020696', 'vitamin b12 deficiency')]		mri of the brain	left-sided	1
33871905			developing interventions to alleviate the motor symptom	[]	treats			motor impairment	[]	mondo:0007739	huntington disease		[]				1
33871905			identifying brain regions	[]	prevents			motor impairment	[]	mondo:0007739	huntington disease		[]				1
33871905			varying-coefficient regression model selection	[]	prevents			motor impairment	[]	mondo:0007739	huntington disease		[]				1
33871905			variable selection method for varying-coefficient regression	[]	prevents			motor impairment	[]	mondo:0007739	huntington disease		[]				1
29932266			fluorodeoxyglucose positron emission tomography (fdg-pet)	[]	treats			cognitive impairment	[('HP:0100543', 'Cognitive impairment'), ('HP:0100543', 'Cognitive impairment')]			neurodegenerative cognitive impairment and dementia	[('MONDO:0001627', 'dementia'), ('MONDO:0001627', 'dementia')]		18 f-fluorodeoxyglucose	mild	1
29932266			fluorodeoxyglucose positron emission tomography (fdg-pet)	[]	treats			cortical dysfunction	[]	mondo:0005180	parkinson's disease		[]	with 18 f-fluorodeoxyglucose	18 f-fluorodeoxyglucose		1
33567536			pcr assay	[]	prevents			neurodegenerative symptoms	[]	mondo:0007739	huntington disease		[]		pcr assay		1
33567536	maxo:0000127	genetic testing		[]	prevents			neurodegenerative symptoms	[]	mondo:0007739	huntington disease		[]				1
33567536			precise cag repeat number determination	[]	prevents			neurodegenerative symptoms	[]	mondo:0007739	huntington disease		[]				1
30206353			predictive testing	[]	prevents			unknown genetic status	[]	mondo:0007739	huntington's disease		[]				1
30206353			discussing the implications of a child's testing	[]	prevents			adverse reactions	[]	mondo:0007739	huntington's disease		[]				1
30206353			ensuring that the candidate is well-informed about the testing options and consequences	[]	prevents			adverse reactions	[]	mondo:0007739	huntington's disease		[]				1
37306313			mri analysis of hippocampal subfields	[]	treats	hp:0002354	memory impairment		[]	mondo:0007739	huntington disease		[]				1
37306313			processed t1-weighted mri	[]	treats			hippocampal dysfunction	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		processed t1-weighted mri		1
37306313			compared volumes of the hippocampal subfields	[]	treats			hippocampal subfields atrophy	[]	mondo:0007739	huntington disease		[]				1
37306313			mixed-model analyses	[]	treats			hippocampal subfields atrophy	[]	mondo:0007739	huntington disease		[]				1
32720531			modulation of gene expression	[]	treats	hp:0002180	neurodegeneration		[]	mondo:0007739	huntington disease		[]		gene therapy		1
32720531			modulation of immune activation	[]	treats	hp:0002180	neurodegeneration		[]	mondo:0007739	huntington disease		[]		immunotherapy		1
32720531	maxo:0001001	gene therapies		[]	treats	hp:0002180	neurodegeneration		[]	mondo:0007739	huntington disease		[]	rna and dna-based	rna and dna-based gene therapies		1
32720531			immuno/antibody-based therapies	[]	treats	hp:0002180	neurodegeneration		[]	mondo:0007739	huntington disease		[]		immuno/antibody-based therapies		1
32235053			phasor fluorescence lifetime imaging microscopy (flim) method	[]	treats			change in energy metabolism	[]	mondo:0007739	huntington disease		[]		fluorescence lifetime imaging microscopy		1
32235053			confocal fluorescence imaging	[]	treats			aggregations of mutant huntingtin proteins	[]	mondo:0007739	huntington disease		[]				1
32235053			phasor fluorescence lifetime imaging microscopy (flim) method	[]	treats			change in energy metabolism	[]	mondo:0007739	huntington disease		[]	with nadh	chebi:16908		1
29786964			oral treatment	[]	treats			multiple sclerosis	[]				[]	with laquinimod	chebi:134738		1
29786964			placebo treatment	[]	prevents			prolongation of qtci	[]	mondo:0005301	multiple sclerosis		[]		placebo		1
29786964			placebo treatment	[]	prevents			prolongation of qtci	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		placebo		1
29786964			electrocardiograms recording	[]	monitors			prolongation of qtci	[]	mondo:0005301	multiple sclerosis		[]		electrocardiograms		1
29786964			electrocardiograms recording	[]	monitors			prolongation of qtci	[]	mondo:0007739	huntington's disease		[]				1
31550618			predictive-saccade paradigm	[]	treats			impaired predictive saccades	[]	mondo:0007739	huntington's disease		[]				1
31550618			structural mri	[]	treats			cognitive deficits	[('HP:0100543', 'Cognitive deficits')]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"				1
31550618			eye movement measurement	[('MAXO:0000972', 'eye movement measurement')]	treats			cognitive deficits	[('HP:0100543', 'Cognitive deficits')]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"				1
30191262			drug-drug interaction (ddi) study	[]	prevents			adverse pharmacokinetic interactions	[]	mondo:0007739	huntington's disease		[]				1
30191262			blood samples for pharmacokinetic profiling	[]	prevents			unknown pharmacokinetic profiles	[]	mondo:0007739	huntington's disease		[]				1
30191262			laquinimod administration	[]	prevents			teratogenicity	[]	mondo:0007739	huntington's disease		[]		chebi:134738	with ethinylestradiol and levonorgestrel	1
29460111			presymptomatic genetic testing	[('MAXO:0000127', 'genetic testing')]	prevents	hp:0002344	progressive neurodegeneration		[]	mondo:0007739	huntington's disease		[]	presymptomatic	genetic testing		1
29460111	maxo:0000079	genetic counseling		[]	treats			concerns	[]			progressive neurodegeneration in huntington disease	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]				1
32370961			mri	[]	treats			rapidly progressive dementia	[('HP:0000726', 'Progressive dementia'), ('HP:0000726', 'Rapidly progressive')]			movement disorders and neurodegenerative diseases	[('MONDO:0005395', 'movement disorder'), ('MONDO:0005395', 'movement disorder')]		mri		1
32370961			imaging	[]	treats			chorea	[('HP:0002072', 'Chorea')]			movement disorders and neurodegenerative diseases	[('MONDO:0005395', 'movement disorder'), ('MONDO:0005395', 'movement disorder')]		imaging		1
32370961			laboratory and genetic tests	[]	treats			movement disorders and neurodegenerative diseases	[('HP:0002180', 'Neurodegenerative disease'), ('HP:0100022', 'Movement disorder')]			parkinsonian syndromes	[('MONDO:0002254', 'syndrome'), ('MONDO:0002254', 'syndromes')]		laboratory and genetic tests	parkinsonian syndromes	1
35771295			spectral-domain optical coherence tomography (sd-oct)	[('MAXO:0000969', 'optical coherence tomography'), ('MAXO:0000969', 'OCT')]	assesses			reduction in macular thickness	[]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"				1
35771295			oct angiography (octa)	[('MAXO:0000969', 'OCT'), ('MAXO:0001259', 'angiography')]	assesses			retinal capillary plexus density	[]	mondo:0007739	huntington disease		[]				1
35771295			generalized estimating equation (gee) model assessment	[]	assesses			visual dysfunction	[]	mondo:0007739	huntington disease		[]	null	null	null	1
34661664			randomized clinical trial	[]	treats			motor and phonic tics	[('HP:0100033', 'Tics'), ('HP:0100035', 'Phonic tics')]	mondo:0007661	tourette syndrome		[]	with deutetrabenazine	deutetrabenazine		1
34661664			titration	[]	treats			motor and phonic tics	[('HP:0100033', 'Tics'), ('HP:0100035', 'Phonic tics')]	mondo:0007661	tourette syndrome		[]	with deutetrabenazine	deutetrabenazine		1
37562878			neuroimaging	[]	treats			diagnosis	[]			motor disorders	[('MONDO:0000001', 'disorder'), ('MONDO:0000001', 'disorders')]				1
37562878			conventional imaging	[]	treats			diagnosis	[]			motor disorders	[('MONDO:0000001', 'disorder'), ('MONDO:0000001', 'disorders')]		computed tomography		1
37562878			magnetic resonance imaging	[]	treats			diagnosis	[]			motor disorders	[('MONDO:0000001', 'disorder'), ('MONDO:0000001', 'disorders')]				1
37562878			diffusion tensor imaging	[]	treats			diagnosis	[]			motor disorders	[('MONDO:0000001', 'disorder'), ('MONDO:0000001', 'disorders')]				1
37562878			volumetric studies	[]	treats			diagnosis	[]			motor disorders	[('MONDO:0000001', 'disorder'), ('MONDO:0000001', 'disorders')]				1
33454006			identify and measure protein aggregates	[]	treats			accumulation	[]	mondo:0004976	amyotrophic lateral sclerosis		[]		aggrecount	misfolded or faulty proteins	1
33454006			identify and measure protein aggregates	[]	treats			protein aggregates	[]	mondo:0004976	amyotrophic lateral sclerosis		[]		aggrecount	insoluble	1
33454006			identify and measure protein aggregates	[]	treats			accumulation of misfolded or faulty proteins	[('HP:0001658', 'MI')]	mondo:0007739	huntington disease		[]		aggrecount		1
33454006			identify and measure protein aggregates	[]	treats			insoluble protein aggregates	[]	mondo:0007739	huntington disease		[]		aggrecount	insoluble protein aggregates	1
33454006			identify and measure protein aggregates	[]	treats			accumulation of misfolded or faulty proteins	[('HP:0001658', 'MI')]	mondo:0004975	alzheimer's disease		[]		aggrecount		1
33454006			identify and measure protein aggregates	[]	treats			insoluble protein aggregates	[]	mondo:0004975	alzheimer's disease		[]		aggrecount	insoluble protein aggregates	1
29358329			preferential binding	[]	prevents			formation of neurotoxic aggregates	[]	mondo:0007739	huntington's disease		[]		profilin		1
29358329			destabilizes aggregation and phase separation	[]	prevents			formation of neurotoxic aggregates	[]	mondo:0007739	huntington's disease		[]				1
29358329			shifting concentration boundaries for phase separation	[]	prevents			formation of neurotoxic aggregates	[]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"	na	na	na	1
30260561			treatment	[]	treats			subcortical hyperactivity	[('HP:0000752', 'Hyperactivity')]	mondo:0007739	huntington's disease		[]		chebi:64312		1
30260561			treatment	[]	treats			reduced sensorimotor resting-state functional-connectivity (rsfc)	[]	mondo:0007739	huntington's disease		[]		chebi:64312		1
30260561			treatment	[]	treats			suppressed structural covariance network (sc)	[]	mondo:0007739	huntington's disease		[]		chebi:64312		1
30260561			treatment	[]	treats			reduced amplitude of low frequency fluctuation covariance in the basal ganglia network	[('HP:0040279', 'Frequency')]	mondo:0007739	huntington's disease		[]		chebi:64312		1
30260561			mri	[]	prevents			misdiagnosis	[('HP:0001658', 'MI')]	mondo:0007739	huntington's disease		[]				1
33636389			neurological examination	[]	treats			clinical progression	[]	mondo:0020380	spinocerebellar ataxia (sca)		[]				1
33636389			brain 3 t mri	[]	treats	hp:0001272	cerebellar atrophy		[]	mondo:0020380	spinocerebellar ataxia (sca)		[]				1
33636389			plasma nfl measurements	[]	treats	hp:0001272	cerebellar atrophy		[]	mondo:0020380	spinocerebellar ataxia (sca)		[]	with neurofilament light chain	neurofilament light chain		1
32627533			development of molecular sensors for amyloidogenic proteins	[]	treats			protein aggregation	[]	mondo:0004975	alzheimer's disease		[]		molecular sensors	amyloidogenic proteins	1
32627533			development of molecular sensors for amyloidogenic proteins	[]	treats			protein aggregation	[]	mondo:0017276	frontotemporal dementia		[]				1
32627533			development of molecular sensors	[]	treats			protein aggregation	[]			parkinson's disease	"[('MONDO:0000001', ""Parkinson's disease""), ('MONDO:0000001', 'disease')]"		amyloidogenic proteins		1
32627533			development of molecular sensors	[]	treats			protein aggregation	[]	mondo:0007739	huntington disease		[]		molecular sensors for amyloidogenic proteins		1
32627533			development of molecular sensors for amyloidogenic proteins	[]	treats			protein aggregation	[]			type-ii diabetes	[('MONDO:0005015', 'diabetes'), ('MONDO:0018849', 'DI')]		molecular sensors for amyloidogenic proteins		1
31203387			analysing animal models	[]	treats			n/a	[]	mondo:0005559	neurodegenerative disease		[]	n/a	n/a	n/a	1
31203387			identifying drug targets	[]	treats			n/a	[]	mondo:0005559	neurodegenerative disease		[]	n/a	n/a	n/a	1
31203387			developing gene therapies	[('MAXO:0001001', 'gene therapies')]	treats			n/a	[]	mondo:0005559	neurodegenerative disease		[]	n/a	n/a	n/a	1
31203387			developing stem cell therapies	[]	treats			n/a	[]	mondo:0005559	neurodegenerative disease		[]	n/a	stem cell therapies	n/a	1
31203387			stratifying patients	[]	prevents			n/a	[]	mondo:0005559	neurodegenerative disease		[]				1
38092268			systemic treatment	[]	treats			motor deficits	[]	mondo:0007739	huntington disease		[]		mab c6-17		1
38092268			systemic treatment	[]	treats			reduced striatal em48 immunoreactivity	[]	mondo:0007739	huntington disease		[]		mab c6-17		1
31586345			construction of clonal cell lines	[]	treats			dna double strand breaks	[]	mondo:0008056	myotonic dystrophy type 1		[]				1
31586345			construction of clonal cell lines	[]	treats			expansions and contractions	[]			myotonic dystrophy type 1	[('MONDO:0008056', 'myotonic dystrophy type 1'), ('MONDO:0008056', 'myotonic dystrophy type 1')]		clonal cell lines	cng microsatellite tracts	1
31586345			construction of clonal cell lines	[]	treats			dna double strand breaks	[]	mondo:0007739	huntington's disease		[]				1
31586345			construction of clonal cell lines	[]	treats			expansions and contractions of cng microsatellite tracts	[('HP:0001658', 'MI')]	mondo:0007739	huntington's disease		[]				1
31586345			construction of clonal cell lines	[]	treats			dna double strand breaks	[]			spinocerebellar ataxia type 8	[('MONDO:0000437', 'spinocerebellar ataxia type 8'), ('MONDO:0100308', 'spinocerebellar ataxia type 8')]				1
31586345			construction of clonal cell lines	[]	treats			expansions and contractions of cng microsatellite tracts	[('HP:0001658', 'MI')]			spinocerebellar ataxia type 8	[('MONDO:0000437', 'spinocerebellar ataxia type 8'), ('MONDO:0100308', 'spinocerebellar ataxia type 8')]	null	null	null	1
35986957			use of machine learning models for assessment	[]	treats			difficulty expressing emotions through voiced language	[]	mondo:0007739	huntington disease		[]		machine learning models		1
35986957			assessment	[]	prevents			misinterpretation of emotion expression assessment	[('HP:0001658', 'MI')]	mondo:0007739	huntington disease		[]	use of	machine learning models		1
29794227			pet imaging	[]	treats			reduction in 11c-abp688 bpnd	[]	mondo:0007739	huntington's disease		[]		11c-abp688		1
29794227			postmortem validation	[]	treats			mglur5 decrease	[]	mondo:0007739	huntington's disease		[]				1
28975278			predictive genetic testing	[('MAXO:0000127', 'genetic testing')]	prevents			motor diagnosis	[]	mondo:0007739	huntington's disease		[]				1
28975278			therapeutic trials	[]	prevents			progression event	[]	mondo:0007739	huntington's disease		[]				1
28975278			therapeutic trials	[]	prevents			total motor score progression	[]	mondo:0007739	huntington's disease		[]		therapeutic trials		1
28975278			therapeutic trials	[]	prevents			cognitive progression	[]	mondo:0007739	huntington's disease		[]				1
29388082			intranasal administration	[]	prevents			depressive-like behaviors	[]	mondo:0007739	huntington's disease		[]		brain-derived neurotrophic factor		1
29388082			intranasal administration	[]	prevents			anhedonic behaviors	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		brain-derived neurotrophic factor		1
29388082			behavioral tests	[]	treats			depressive-like behaviors	[]	mondo:0007739	huntington's disease		[]				1
29388082			increase in adult hippocampal neurogenesis	[]	treats			depressive-like behaviors	[]	mondo:0007739	huntington's disease		[]				1
29388082			increase in cell proliferation	[]	treats			depressive-like behaviors	[]	mondo:0007739	huntington's disease		[]				1
29581083			psychological support	[]	prevents			psychological disturbance	[]	mondo:0007739	huntington's disease		[]				1
29581083			pre-symptomatic testing (pst)	[]	prevents			psychological disturbance	[]	mondo:0007739	huntington's disease		[]				1
29581083			regression analysis	[]	treats			psychological disturbance	[]	mondo:0007739	huntington's disease		[]		regression analysis		1
29581083			application of an evaluation instrument	[]	treats			psychological disturbance	[]	mondo:0007739	huntington's disease		[]		evaluation instrument		1
34239038			cryo-electron tomography	[]	provides insights into			formation of filamentous mhtt inclusions in the brain	[]	mondo:0007739	huntington disease		[]				1
34239038			subtomogram averaging	[]	provides insights into			formation of filamentous mhtt inclusions in the brain	[]	mondo:0007739	huntington disease		[]				1
29520722	maxo:0000016	cell therapy		[]	treats			progressive deterioration of specific neurons	[('HP:0003676', 'Progressive')]	mondo:0007739	huntington's disease		[]				1
29520722			isolation and characterization	[]	treats			oxidative stress-induced cell death	[('HP:0025464', 'Oxidative stress')]	mondo:0007739	huntington's disease		[]		umbilical cord matrix stem cells (ucmscs)		1
29520722			synthesis	[]	treats			cognitive anomalies	[]	mondo:0007739	huntington's disease		[]	with gdnf	neurotrophic factors		1
29520722			synthesis of neurotrophic factors	[]	treats			movement anomalies	[]	mondo:0007739	huntington's disease		[]		neurotrophic factors	with vegf	1
29520722	maxo:0000068	transplantation		[]	prevents			motor function anomalies	[]	mondo:0007739	huntington's disease		[]		ucmsc		1
29520722	maxo:0000068	transplantation		[]	prevents			striatal atrophy	[]	mondo:0007739	huntington's disease		[]		ucmsc		1
29520722			assessment of cell viability and neuritogenesis	[]	treats			oxidative stress-induced cell death	[('HP:0025464', 'Oxidative stress')]	mondo:0007739	huntington's disease		[]				1
29520722			protection against oxidative stress	[]	prevents			progressive deterioration of specific neurons	[('HP:0003676', 'Progressive')]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		oxidative stress protection		1
29282329			investigating microrna levels in csf	[]	prevents			clinical diagnosis	[]	mondo:0007739	huntington's disease		[]		microrna levels	imminent clinical diagnosis	1
29282329			measuring mirna levels in csf	[]	prevents			imminent clinical diagnosis	[]	mondo:0007739	huntington's disease		[]		htg protocol		1
29282329			selection based on cag-age product score	[]	prevents			imminent clinical diagnosis	[]	mondo:0007739	huntington's disease		[]		cag-age product score		1
29282329			evaluation of mirna levels	[]	prevents			imminent clinical diagnosis	[]	mondo:0007739	huntington's disease		[]	in hd risk categories			1
30971481			assessment of brain morphometry	[]	treats			reduced intracranial volumes	[]			juvenile-onset huntington disease (johd)	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]				1
30971481			mri	[]	treats			decreased volumes of subcortical regions (caudate, putamen, globus pallidus, thalamus)	[]			juvenile-onset huntington disease (johd)	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]		mri		1
30971481			cross-sectional study	[]	treats			decreased volume of cortical white matter	[]			juvenile-onset huntington disease	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]				1
30971481			assessment of brain morphometry	[]	treats	hp:0012081	enlarged cerebellum		[]			juvenile-onset huntington disease	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]				1
29620999			use of antisense oligonucleotides	[]	treats			mutant huntingtin protein	[]	mondo:0007739	huntington's disease		[]		chebi:76720	mutant huntingtin protein	1
29620999			safety and tolerability assessment	[]	treats			huntington disease	[]				[]				1
29089255			symptomatic treatments	[]	treats	hp:0002072	chorea		[]	mondo:0007739	huntington's disease		[]				1
29089255			surgical therapies	[]	treats			huntington disease	[]				[]				1
29089255			exercise-based physical interventions	[]	treats			huntington disease	[]				[]				1
29089255	maxo:0000021	palliative care		[]	prevents			nursing home placement	[]	mondo:0007739	huntington's disease		[]				1
32499373			facs-array-based cell purification	[]	prevents			contamination with non-msn cells	[]	mondo:0007739	huntington disease		[]				1
32499373			gene microarrays	[]	treats			lack of insight into msn-specific gene expression changes	[('HP:0000757', 'Lack of insight'), ('HP:0000757', 'Lack of insight')]	mondo:0007739	huntington disease		[]		gene microarrays	msn-specific gene expression changes	1
32499373			comparative gene expression approach	[]	treats			masked critical genes in hd etiology or pathology	[]	mondo:0007739	huntington disease		[]	facs-array			1
30007561			intracranial administration	[]	treats			neurodegenerative disorder	[]	mondo:0007739	huntington's disease		[]	with engineered microrna	aav5-mihtt	engineered microrna	1
36098670			administration of deutetrabenazine	[]	treats	hp:0002072	chorea		[]	mondo:0007739	huntington disease		[]		deutetrabenazine		1
36098670			administration of deutetrabenazine	[]	treats	hp:0040141	tardive dyskinesia		[]	mondo:0010096	tardive dyskinesia		[]		deutetrabenazine		1
36098670			pharmacokinetic exposure determination	[]	prevents			qt interval prolongation	[]			huntington disease, tardive dyskinesia	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]		pharmacokinetic exposure determination		1
36098670			concentration-qtc analysis	[]	prevents			qt interval prolongation	[]			huntington disease, tardive dyskinesia	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]		c-qtc analysis		1
35618525			in vitro fertilization	[]	prevents			huntington disease	[]	mondo:0007739	huntington disease		[]		preimplantation genetic testing	early/normal/late-onset	1
35618525			prenatal diagnosis	[]	treats			early/normal/late-onset huntington disease	[('HP:0003674', 'Onset')]	mondo:0007739	huntington disease		[]				1
37652706			continuous video electroencephalography	[('MAXO:0000932', 'electroencephalography')]	treats			seizures	[('HP:0001250', 'Seizures'), ('HP:0001250', 'Seizure')]			pediatric-onset huntington's disease	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]				1
37652706			treatment	[]	treats			epileptic myoclonic jerks	[('HP:0001336', 'Myoclonic jerks')]			pediatric-onset huntington's disease	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]				1
34663644			pet imaging study	[]	treats			synaptic damage	[]	mondo:0007739	huntington disease		[]	with 11c-ucb-j	11c-ucb-j		1
34663644			pet imaging study	[]	treats			reduced 18f-fdg uptake	[]	mondo:0007739	huntington disease		[]	with 18f-fluorodeoxyglucose (18f-fdg)	18f-fluorodeoxyglucose (18f-fdg)		1
34663644			clinical assessment of motor and nonmotor manifestations	[('MAXO:0000487', 'clinical assessment')]	treats			motor impairment	[]	mondo:0007739	huntington disease		[]				1
34663644			correlation calculations	[]	treats			synaptic damage	[]	mondo:0007739	huntington disease		[]	clinical scores	pet data	synaptic damage	1
36706436			hospice	[]	treats			end-of-life care	[]	mondo:0007739	huntington disease		[]				1
28947128			biomarker identification	[]	prevents			progression	[]	mondo:0007739	huntington's disease		[]				1
28947128			intervention or modification of disease mechanisms	[]	prevents			progression	[]	mondo:0007739	huntington's disease		[]				1
28947128			identifying disease processes	[]	prevents			progression	[]	mondo:0007739	huntington's disease		[]				1
31771445			social cognition impairment	[]	prevents			progressive motor dysfunction	[('HP:0003676', 'Progressive')]	mondo:0007739	huntington disease		[]				1
31771445			social cognition impairment	[]	prevents			behavioral dysfunction	[]	mondo:0007739	huntington disease		[]				1
31771445			social cognition impairment	[]	prevents	hp:0100543	cognitive impairment		[]	mondo:0007739	huntington disease		[]				1
31771445			significant impairment of theory of mind abilities	[('MAXO:0009028', 'ABI')]	prevents			social cognition impairment	[]	mondo:0007739	huntington disease		[]				1
31771445			discrete motor symptoms	[]	prevents			progressive motor dysfunction	[('HP:0003676', 'Progressive')]	mondo:0007739	huntington disease		[]				1
37751638			longitudinal mri scans	[]	treats			shape change of the striatum	[]	mondo:0007739	huntington disease		[]				1
37751638			statistical shape analysis	[]	treats			shape change of the striatum	[]	mondo:0007739	huntington disease		[]				1
37751638			spherical harmonic point distribution method (spharm-pdm)	[]	treats			shape change of the striatum	[]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"		spherical harmonic point distribution method (spharm-pdm)		1
37751638			linear mixed models	[]	treats			shape change of the striatum	[]	mondo:0007739	huntington disease		[]				1
37751638			longitudinal mri scans	[]	prevents			deflation of the striatum	[]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"		mri scans		1
37751638			statistical shape analysis	[]	prevents			deflation of the striatum	[]	mondo:0007739	huntington disease		[]				1
37751638			spherical harmonic point distribution method (spharm-pdm)	[]	prevents			deflation of the striatum	[]	mondo:0007739	huntington disease		[]				1
37751638			linear mixed models	[]	prevents			deflation of the striatum	[]	mondo:0007739	huntington disease		[]				1
29169178			administration of the epworth sleepiness scale	[]	treats	hp:0002329	sleepiness		[]	mondo:0007739	huntington's disease		[]				1
29169178			administration	[]	treats			poor sleep quality	[('HP:0002725', 'SLE')]	mondo:0007739	huntington's disease		[]		pittsburgh sleep quality index		1
36513779			cognition-oriented treatments	[]	treats	hp:0100543	cognitive impairment		[]	mondo:0007739	huntington disease		[]				1
36513779			physical exercise	[]	treats			cognitive function decline	[]	mondo:0007739	huntington disease		[]				1
36513779			cognitive training	[]	treats	hp:0100543	cognitive impairment		[]	mondo:0007739	huntington disease		[]	within cognition-oriented treatments			1
36513779			cognitive rehabilitation (combined with physical exercise)	[]	treats	hp:0100543	cognitive impairment		[]	mondo:0007739	huntington disease		[]				1
36513779			cognitive stimulation (combined with physical exercise)	[]	treats	hp:0100543	cognitive impairment		[]	mondo:0007739	huntington disease		[]	combined with physical exercise	cognitive stimulation		1
29240846			determination of mtdna copy number	[]	prevents			mitochondrial abnormalities	[('HP:0001427', 'Mitochondrial abnormalities'), ('HP:0001427', 'Mitochondrial')]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		mtdna copy number	mitochondrial abnormalities	1
29240846			optimization of technical conditions for analysis	[]	prevents			discrepancies in assessment	[]	mondo:0007739	huntington's disease		[]				1
29240846			biological sample collection and storage	[]	prevents			inaccurate estimation	[]	mondo:0007739	huntington's disease		[]				1
29240846			estimation	[]	prevents			mitochondrial abnormalities	[('HP:0001427', 'Mitochondrial abnormalities'), ('HP:0001427', 'Mitochondrial')]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		mtdna level relative to ndna		1
31436908			predictive testing	[]	treats			none	[]	mondo:0007739	huntington's disease		[]				1
31436908			assessment of symptoms by a neurologist	[]	treats			motor signs	[]	mondo:0007739	huntington's disease		[]	with none			1
31436908			assessment of symptoms by a neurologist	[]	treats			cognitive signs	[]	mondo:0007739	huntington's disease		[]	with none			1
30334188			treatment	[]	treats			motor learning deficits	[]	mondo:0007739	huntington's disease		[]		chebi:134738		1
30334188			treatment	[]	treats			motor function deficits	[]	mondo:0007739	huntington's disease		[]		chebi:134738		1
30334188			laquinimod treatment	[]	treats			myelination deficits	[]	mondo:0007739	huntington's disease		[]	with laquinimod	chebi:134738		1
30334188			laquinimod treatment	[]	treats			changes in myelin sheath thickness	[]	mondo:0007739	huntington's disease		[]	with laquinimod	chebi:134738		1
30334188			laquinimod treatment	[]	treats			mbp mrna and protein deficits	[]	mondo:0007739	huntington's disease		[]	with laquinimod	chebi:134738		1
30056431			assessment for suicidal ideation	[]	treats	hp:0031589	suicidal ideation		[]	mondo:0007739	huntington's disease		[]				1
30056431			assessment for suicidal ideation	[]	treats			suicidal plans	[]	mondo:0007739	huntington's disease		[]				1
30179155			employing in vivo two-photon ca2+ imaging	[]	prevents			increase in activity	[]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"		in vivo two-photon ca2+ imaging		1
30179155			in vivo two-photon ca2+ imaging	[]	prevents			enhanced synchronicity	[]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"	n/a	in vivo two-photon ca2+ imaging	n/a	1
30179155			in vivo two-photon ca2+ imaging	[]	prevents			hyperactive neurons	[]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"		in vivo two-photon ca2+ imaging		1
30179155			metformin	[]	treats			increase in activity	[]	mondo:0007739	huntington's disease		[]	with metformin	chebi:6801		1
30179155			metformin	[]	treats			enhanced synchronicity	[]	mondo:0007739	huntington's disease		[]	with metformin	chebi:6801		1
30179155			metformin	[]	treats			hyperactive neurons	[]	mondo:0007739	huntington's disease		[]	with metformin	chebi:6801		1
30179155			metformin	[]	treats			aberrations in animal behavior	[]	mondo:0007739	huntington's disease		[]	with metformin	chebi:6801		1
34120903			detection of mild cognitive impairment	[]	treats			impaired emotion recognition	[]	mondo:0001627	dementias		[]				1
33974252			pcr	[]	treats			huntington disease	[]				[]				1
33974252			capillary gel electrophoresis	[]	treats			huntington disease	[]				[]				1
33974252			pre-symptomatic testing	[]	prevents			birth of affected children	[('HP:0032320', 'Affected')]	mondo:0007739	huntington disease		[]				1
37591545			mri-guided intrastriatal delivery	[]	treats	hp:0002180	neurodegeneration		[]	mondo:0007739	huntington disease		[]	with aav2 and aav2.retro expressing htt fragment	aav2 and aav2.retro expressing htt fragment		1
37591545			pet/ct imaging	[('MAXO:0000571', 'CT')]	treats	hp:0002180	neurodegeneration		[]	mondo:0007739	huntington disease		[]	using	11c-chdi-180r		1
37591545			visualization and quantification of cerebral mhtt	[('MAXO:0000744', 'MHT')]	treats	hp:0002180	neurodegeneration		[]	mondo:0007739	huntington disease		[]	using	11c-chdi-180r		1
37591545			immunostaining	[]	treats	hp:0002180	neurodegeneration		[]	mondo:0007739	huntington disease		[]		mhtt		1
37591545			calculating total volume of distribution	[]	treats	hp:0002180	neurodegeneration		[]	mondo:0007739	huntington disease		[]		2-tissue-compartment model		1
37591545			regional quantification	[]	treats			neurodegeneration	[('HP:0002180', 'Neurodegeneration')]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		logan graphical analysis		1
30391555			viewrna in situ hybridization	[]	treats			expression changes	[]	mondo:0007739	huntington's disease		[]				1
32743645			bolus infusion	[('MAXO:0000757', 'infusion')]	treats			huntington disease	[]	mondo:0007739	huntington disease		[]	with quinolinic acid	chebi:16675		1
32743645			magnetic resonance spectroscopy	[('MAXO:0009070', 'SPECT')]	monitors			decrease in n-acetylaspartate	[]	mondo:0007739	huntington disease		[]				1
32743645			diffusion tensor imaging	[]	monitors			decrease in fractional anisotropy	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		diffusion tensor imaging (dti)		1
32743645			measurement	[]	monitors			death and/or impairment of neurons	[]	mondo:0007739	huntington disease		[]		metabolite concentrations	acute	1
32743645			measurement of fractional anisotropy	[]	monitors			acute structural disruption	[('HP:0011009', 'Acute')]	mondo:0007739	huntington disease		[]				1
32743645			magnetic resonance spectroscopy (mrs)	[('MAXO:0009070', 'SPECT')]	monitors			re-organization and glial cell infiltration	[]	mondo:0007739	huntington disease		[]				1
32590293			restoration of the oxytocin-vasopressin interplay	[]	treats	hp:0000716	depression		[]	mondo:0007739	huntington disease		[]	with an acute dose of intranasal	chebi:7872		1
32590293			restoration of the oxytocin-vasopressin interplay	[]	does not treat	hp:0000739	anxiety		[]	mondo:0007739	huntington disease		[]	with an acute dose of intranasal	chebi:7872		1
32700226			evaluation using optical coherence tomography angiography	[('MAXO:0000969', 'optical coherence tomography'), ('MAXO:0001259', 'angiography')]	treats			changes in choroidal structure	[]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"		optical coherence tomography angiography		1
32700226			measurement using enhanced depth imaging spectral-domain oct (edi sd-oct)	[('MAXO:0000969', 'OCT'), ('MAXO:0009070', 'SPECT')]	treats			thinner central choroidal thickness (cct)	[('HP:0030645', 'Central')]	mondo:0007739	huntington disease		[]				1
36409538			assessing motor functions with digital devices	[]	treats			impaired mobility	[]	mondo:0005180	parkinson disease		[]		digital devices		1
36409538			assessing motor functions with digital devices	[]	treats			gait issues	[]	mondo:0005098	stroke		[]		digital devices		1
36409538			continuous and objective monitoring of motor function outcomes	[]	treats			gross motor movement difficulties	[]	mondo:0007739	huntington disease		[]				1
36409538			clinical validation	[]	treats			fine motor movement difficulties	[]	mondo:0005301	multiple sclerosis		[]		sensor-derived motion data		1
33571915			comparing crude markers of ans function	[]	prevents			autonomic nervous system dysfunction	[]	mondo:0007739	huntington disease		[]				1
33571915			linear mixed effects regression models	[('MAXO:0000775', 'EFF')]	treats			elevated resting heart rate	[('HP:0001370', 'RA')]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		linear mixed effects regression models		1
33571915			linear mixed effects regression models	[('MAXO:0000775', 'EFF')]	treats			elevated core body temperature	[('HP:0500001', 'BO')]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		linear mixed effects regression models		1
33571915			linear mixed effects regression models	[('MAXO:0000775', 'EFF')]	treats	hp:0004421	elevated systolic blood pressure		[]	mondo:0007739	huntington disease		[]				1
32775019	maxo:0000127	genetic testing		[]	prevents			huntington disease phenocopies	[]	mondo:0007739	huntington disease		[]		c9orf72 expansions	huntington-disease like phenotypes	1
32775019			screened for the c9orf72 expansion	[]	treats			huntington disease phenocopies	[]	mondo:0007739	huntington disease		[]		c9orf72 expansion	huntington-disease like phenotypes	1
33377823	maxo:0000079	genetic counseling		[]	prevents			progression	[]	mondo:0007739	huntington disease		[]				1
33377823	maxo:0000079	genetic counseling		[]	treats			requirement of 24-hr supervision	[]	mondo:0007739	huntington disease		[]				1
30282372			treatment initiation	[]	treats			motor impairments	[]	mondo:0007739	huntington's disease		[]	with tetrabenazine	chebi:9467		1
30282372			non-initiation	[]	prevents			intolerability	[]	mondo:0007739	huntington's disease		[]				1
30282372			dose adjustments	[]	treats	hp:0002072	chorea		[]	mondo:0007739	huntington's disease		[]				1
30282372			discontinuation	[]	prevents			intolerability	[]	mondo:0007739	huntington's disease		[]				1
30282372			upward titration	[]	treats	hp:0002072	chorea		[]	mondo:0007739	huntington's disease		[]				1
32160851			stem cell therapy	[('MAXO:0000016', 'cell therapy'), ('MAXO:0001298', 'therapy')]	treats			huntington disease	[]			stem cell therapies	[('MONDO:0015687', 'CEL')]		stem cell therapy		1
32160851			stem cell therapy	[('MAXO:0000016', 'cell therapy'), ('MAXO:0001298', 'therapy')]	treats			parkinson's disease	[]			stem cell therapies	[('MONDO:0015687', 'CEL')]		stem cell therapy		1
32160851			stem cell therapy	[('MAXO:0000016', 'cell therapy'), ('MAXO:0001298', 'therapy')]	treats			spinal cord injury	[]			stem cell therapies	[('MONDO:0015687', 'CEL')]				1
32160851			stem cell therapy	[('MAXO:0000016', 'cell therapy'), ('MAXO:0001298', 'therapy')]	treats			cerebral palsy	[('HP:0100021', 'Cerebral palsy')]			stem cell therapies	[('MONDO:0015687', 'CEL')]		stem cell		1
32160851			stem cell therapy	[('MAXO:0000016', 'cell therapy'), ('MAXO:0001298', 'therapy')]	treats			aplastic anemia	[('HP:0001903', 'Aplastic anemia'), ('HP:0001915', 'Anemia')]			stem cell therapies	[('MONDO:0015687', 'CEL')]		stem cell		1
32160851			stem cell therapy	[('MAXO:0000016', 'cell therapy'), ('MAXO:0001298', 'therapy')]	treats			multiple sclerosis	[]			stem cell therapies	[('MONDO:0015687', 'CEL')]		stem cell		1
32160851			stem cell therapy	[('MAXO:0000016', 'cell therapy'), ('MAXO:0001298', 'therapy')]	prevents			immune rejection	[]			stem cell therapies	[('MONDO:0015687', 'CEL')]				1
32160851			stem cell therapy	[('MAXO:0000016', 'cell therapy'), ('MAXO:0001298', 'therapy')]	prevents			teratoma formation	[('HP:0009792', 'Teratoma')]			stem cell therapies	[('MONDO:0015687', 'CEL')]				1
28947129			assessment and counseling	[]	prevents			high anxiety	[('HP:0000739', 'Anxiety'), ('HP:0000739', 'Anxiety')]	mondo:0007739	huntington's disease		[]				1
28947129			exploration of motivations	[]	prevents			high anxiety	[('HP:0000739', 'Anxiety'), ('HP:0000739', 'Anxiety')]	mondo:0007739	huntington's disease		[]				1
28947129			offering support	[]	prevents			high anxiety	[('HP:0000739', 'Anxiety'), ('HP:0000739', 'Anxiety')]	mondo:0007739	huntington's disease		[]				1
28947129			assessment and counseling	[]	prevents	hp:0000716	depression		[]	mondo:0007739	huntington's disease		[]				1
28947129			exploration of motivations	[]	prevents	hp:0000716	depression		[]	mondo:0007739	huntington's disease		[]				1
28947129			offering support	[]	prevents	hp:0000716	depression		[]	mondo:0007739	huntington's disease		[]				1
34543681			subcutaneous injections	[]	prevents			motor coordination decline	[]	mondo:0007739	huntington disease		[]		mncl[2] tetrahydrate		1
34543681			subcutaneous injections	[]	treats			exploratory behavior changes	[]	mondo:0007739	huntington disease		[]	with manganese (mn)	mncl[2] tetrahydrate		1
34543681			subcutaneous injections	[]	treats			total activity changes	[]	mondo:0007739	huntington disease		[]		mncl[2] tetrahydrate	with manganese (mn)	1
34543681			subcutaneous injections	[]	prevents			decrease in striatal neun positive cell density	[]	mondo:0007739	huntington disease		[]	with manganese (mn)	mncl[2] tetrahydrate	manganese (mn)	1
30336474			genotyping pcr	[]	prevents			hd-like phenotypes	[]	mondo:0007739	huntington's disease		[]				1
30336474			southern blot	[]	prevents			hd-like phenotypes	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		southern blot		1
30336474			5' repeat methylation status assessment by combined repeat-primed and methylation-specific pcr	[]	prevents			hd-like phenotypes	[]	mondo:0007739	huntington's disease		[]				1
30336474			c9orf72 repeat expansion testing	[]	prevents			hd-like phenotypes	[]	mondo:0007739	huntington's disease		[]		c9orf72 repeat expansion testing		1
30336474			c9orf72 evaluation	[]	prevents			hd-like phenotypes	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		c9orf72 evaluation		1
36429634			home-based exercises	[]	treats			motor dysfunction	[]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"				1
36429634			home-based exercises	[]	treats			reduced quality of life	[]	mondo:0007739	huntington disease		[]				1
31708117			suppression of mutant htt	[]	treats			fatal neurodegenerative disorder	[]	mondo:0007739	huntington's disease		[]				1
31708117			allele-selective approaches targeting	[]	treats			neurodegenerative disorder	[]	mondo:0007739	huntington's disease		[]		htt snps	fatal	1
31708117			gene silencing	[]	treats			fatal neurodegenerative disorder	[]	mondo:0007739	huntington's disease		[]				1
31708117			preclinical development	[]	treats			fatal neurodegenerative disorder	[]	mondo:0007739	huntington's disease		[]		asos		1
35649655			pet imaging	[]	treats			synaptic loss	[]			neurodegenerative disorders	[('MONDO:0000001', 'disorder'), ('MONDO:0000001', 'disorders')]		sv2a		1
35649655			development of sv2a tracers (with 11c-ucb-j)	[]	treats			synaptic loss	[]			neurodegenerative disorders	[('MONDO:0000001', 'disorder'), ('MONDO:0000001', 'disorders')]		sv2a tracers		1
35649655			human blocking studies	[]	prevents			synaptic loss	[]			neurodegenerative disorders	[('MONDO:0000001', 'disorder'), ('MONDO:0000001', 'disorders')]	with levetiracetam	chebi:6437		1
31437969			gait analysis	[]	treats			impaired balance	[]	mondo:0007739	huntington's disease		[]	using	footstep pressure sensor mats		1
31437969			classifying patient disease severity	[]	treats	hp:0004305	involuntary movements		[]	mondo:0007739	huntington's disease		[]		deep learning techniques		1
31437969			using the motor subscale of the unified hd rating scale (uhdrs)	[]	treats	hp:0004305	involuntary movements		[]	mondo:0007739	huntington's disease		[]				1
31437969			image pre-processing	[]	treats	hp:0004305	involuntary movements		[]	mondo:0007739	huntington's disease		[]				1
31103310			nordic walking training	[]	improves			functional capacity	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]				1
31351096			systematic initial data analysis	[]	treats			motor impairment	[]	mondo:0008199	<parkinson's disease (pd); huntington disease (hd)>		[]				1
31351096			systematic initial data analysis	[]	treats			motor impairment	[]	mondo:0007739	huntington's disease		[]				1
31351096			utilizing heat-maps for data reporting	[]	treats			motor impairment	[]	mondo:0008199	<parkinson's disease (pd); huntington disease (hd)>		[]		heat-maps		1
31351096			data reporting	[]	treats			motor impairment	[]	mondo:0007739	huntington's disease		[]	utilizing	heat-maps		1
33556538			super-resolution imaging	[]	treats			synaptic dysfunction	[]	mondo:0007739	huntington disease		[]				1
33556538			multi-electrode array electrophysiology	[]	treats			synaptic dysfunction	[]	mondo:0007739	huntington disease		[]		multi-electrode array electrophysiology		1
29105741	maxo:0000127	genetic testing		[]	treats			huntington disease	[]				[]				1
29105741			predictive testing	[]	treats			huntington disease	[]				[]				1
29105741			prenatal testing	[]	treats			huntington disease	[]				[]				1
37202171			mri	[]	treats			progressive language impairment	[('HP:0002463', 'Language impairment'), ('HP:0003676', 'Progressive')]	mondo:0007739	huntington disease		[]				1
37202171			fdg pet/ct	[('MAXO:0000571', 'CT')]	treats			progressive language impairment	[('HP:0002463', 'Language impairment'), ('HP:0003676', 'Progressive')]	mondo:0007739	huntington disease		[]		fdg pet/ct		1
37202171			huntingtin gene testing	[]	treats	hp:0002072	chorea		[]	mondo:0007739	huntington disease		[]				1
29143208			qualitative focus groups	[]	treats			lack of measures for end of life planning	[]	mondo:0007739	huntington's disease		[]				1
29143208			expert input	[]	treats			lack of measures for end of life planning	[]	mondo:0007739	huntington's disease		[]				1
29143208			literature review	[]	treats			lack of measures for end of life planning	[]	mondo:0007739	huntington's disease		[]				1
29143208			item response theory analysis	[]	treats			lack of measures for end of life planning	[]	mondo:0007739	huntington's disease		[]		item response theory analysis		1
29143208			differential item functioning analysis	[]	treats			lack of measures for end of life planning	[]	mondo:0007739	huntington's disease		[]				1
29143208			exploratory factor analysis	[]	treats			lack of measures for end of life planning	[]	mondo:0007739	huntington's disease		[]				1
33246883			cell replacement therapy (crt)	[('MAXO:0001298', 'therapy')]	treats			str degeneration	[]	mondo:0007739	huntington disease		[]				1
28971447	maxo:0000079	genetic counseling		[]	prevents			genetic disorder	[]	mondo:0007739	huntington's disease		[]				1
28971447			presymptomatic testing	[]	prevents			unknowledgeable progression	[]	mondo:0007739	huntington's disease		[]				1
28971447			prenatal testing	[]	prevents			birth of affected individuals	[('HP:0032320', 'Affected')]	mondo:0007739	huntington's disease		[]				1
28971447			symptomatic treatment	[]	treats			trinucleotide repeat expansion	[]	mondo:0007739	huntington's disease		[]				1
28971447			gene silencing technologies	[]	treats			trinucleotide repeat expansion	[]	mondo:0007739	huntington's disease		[]		gene silencing technologies		1
33749915	maxo:0000016	cell therapy		[]	treats			huntington's disease	[]				[]				1
32674730			gene therapy	[('MAXO:0001001', 'gene therapy'), ('MAXO:0001298', 'therapy')]	treats			neuroinflammation	[('HP:0033429', 'Neuroinflammation')]			neurological disorders	[('MONDO:0000001', 'neurological disorder'), ('MONDO:0000001', 'disorder')]		gene therapy		1
32674730	maxo:0001001	gene therapies		[]	treats	hp:0002180	neurodegeneration		[]	mondo:0005071	neurological disorders		[]		gene therapy		1
32674730			gene therapy	[('MAXO:0001001', 'gene therapy'), ('MAXO:0001298', 'therapy')]	treats			cognitive dysfunction	[]			neurological disorders	[('MONDO:0000001', 'neurological disorder'), ('MONDO:0000001', 'disorder')]		gene therapy		1
32674730			deletion, silencing or edition	[]	treats	hp:0033429	neuroinflammation		[]	mondo:0005071	neurological disorders		[]		faulty genes		1
32674730			deletion, silencing or edition of faulty genes	[]	treats			neurodegeneration	[('HP:0002180', 'Neurodegeneration')]			neurological disorders	[('MONDO:0000001', 'neurological disorder'), ('MONDO:0000001', 'disorder')]		faulty genes		1
32674730			deletion, silencing or edition	[]	treats	hp:0100543	cognitive impairment		[]	mondo:0005071	neurological disorders		[]		faulty genes		1
32674730			insertion	[]	treats	hp:0033429	neuroinflammation		[]	mondo:0005071	neurological disorders		[]		healthier genes		1
32674730			insertion	[]	treats	hp:0002180	neurodegeneration		[]	mondo:0005071	neurological disorders		[]		healthier genes		1
32674730			insertion	[]	treats	hp:0100543	cognitive impairment		[]	mondo:0005071	neurological disorders		[]		healthier genes		1
38272260			systematic literature review	[]	treats			lack of information	[]			euthanasia and assisted suicide	[]				1
38272260			diminished decision-making capacity	[]	prevents			informed consent	[]			euthanasia and assisted suicide	[]				1
35396899			in vivo ultra-strong gradient mri	[]	treats			lower magnetization transfer ratio (mtr) in callosal rostrum	[]	mondo:0007739	huntington disease		[]		ultra-strong gradient mri		1
35396899			in vivo ultra-strong gradient mri	[]	treats			higher mtr in splenium	[]	mondo:0007739	huntington disease		[]		ultra-strong gradient mri		1
35396899			in vivo ultra-strong gradient mri	[]	treats			higher restricted diffusion signal fraction	[]	mondo:0007739	huntington disease		[]		ultra-strong gradient mri	higher restricted diffusion signal fraction	1
36270767			presymptomatic testing	[]	prevents			disease transmission	[]			neurogenetic diseases	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]	not provided because the text does not include a specific qualifier or modifier for the subject	not provided because the text does not specify a chemical or drug	not provided because the text does not specify a specific aspect of the object	1
36270767			medically assisted reproduction	[]	treats	hp:0000789	infertility		[]			neurogenetic diseases	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]				1
36270767			prenatal diagnosis	[]	treats or prevents			disease transmission	[]			neurogenetic diseases	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]		prenatal diagnosis		1
36270767			preimplantation diagnosis	[]	treats or prevents			disease transmission	[]			neurogenetic diseases	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]		preimplantation diagnosis		1
36270767			termination of pregnancy	[]	prevents			disease transmission	[]			neurogenetic diseases	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]				1
36270767			gamete donation	[]	treats	hp:0000789	infertility		[]			neurogenetic diseases	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]				1
36270767			pregnancy abstention	[]	prevents			disease transmission	[]			neurogenetic diseases	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]				1
33310205	maxo:0009004	exome sequencing		[]	treats			incomplete diagnosis	[]			broad range of neurological phenotypes	[('MONDO:0005272', 'RA'), ('MONDO:0008383', 'RA')]				1
33310205			extended bioinformatics repeat expansion analysis	[]	treats			incomplete diagnosis	[]			broad range of neurological phenotypes	[('MONDO:0005272', 'RA'), ('MONDO:0008383', 'RA')]				1
33310205			genomic data analysis	[]	treats			incomplete diagnosis	[]			broad range of neurological phenotypes	[('MONDO:0005272', 'RA'), ('MONDO:0008383', 'RA')]	using	virtual gene panels		1
36881978			comparative transcriptome analysis	[]	identifies			sperm motility issues	[]			drakes	[('MONDO:0019440', 'DRA')]		crucial genes		1
36881978			identifies	[]	in			crucial genes	[]			sperm motility issues	[('MONDO:0010367', 'ISS')]		rna-seq		1
35234162			in-hospital intensive rehabilitation	[]	treats			low body mass index	[('HP:0500001', 'BO')]	mondo:0007739	huntington disease		[]	in-hospital			1
35234162			in-hospital intensive rehabilitation	[]	treats			progressive body weight loss	[('HP:0001824', 'Weight loss'), ('HP:0003676', 'Progressive')]	mondo:0007739	huntington disease		[]				1
35234162			in-hospital intensive rehabilitation	[]	prevents			risk of malnutrition	[('HP:0004395', 'Malnutrition'), ('HP:0004395', 'Malnutrition')]	mondo:0007739	huntington disease		[]				1
33538666			use	[]	treats	hp:0025464	oxidative stress		[]	mondo:0005071	neurological disorders		[]		withania somnifera		1
33538666			use	[]	treats			inflammation	[]	mondo:0005071	neurological disorders		[]		withania somnifera		1
33538666			use	[]	prevents			aging	[]	mondo:0005071	neurological disorders		[]		withania somnifera	neurological disorders	1
33538666			use of withania somnifera	[]	treats			parkinson's disease	[]	mondo:0005071	neurological disorders		[]		withania somnifera		1
33538666			use of withania somnifera	[]	treats	hp:0002511	alzheimer's disease		[]	mondo:0005071	neurological disorders		[]		withania somnifera		1
33538666			use	[]	treats			huntington disease	[]	mondo:0005071	neurological disorders		[]		withania somnifera		1
33538666			use of withania somnifera	[]	treats	hp:0040141	tardive dyskinesia		[]	mondo:0005071	neurological disorders		[]		withania somnifera		1
33538666			use of withania somnifera	[]	treats	hp:0001297	stroke		[]	mondo:0005071	neurological disorders		[]		withania somnifera		1
33538666			use of withania somnifera	[]	treats	hp:0000739	anxiety		[]	mondo:0005071	neurological disorders		[]		withania somnifera		1
33538666			treatment	[]	treats			neurological disorders	[]	mondo:0005071	neurological disorders		[]		polymeric nanomicelles, nanoparticles, and nanofibers		1
31219985			nursing-care strategies	[]	prevents			worsening symptoms	[]	mondo:0007739	huntington's disease		[]				1
31219985			early recognition	[]	treats			huntington disease	[]				[]				1
31219985			prioritize a plan of care	[]	prevents			complications	[]	mondo:0007739	huntington's disease		[]				1
31219985			clinical presentation	[]	identifies			huntington disease	[]				[]				1
31845872			rna therapy	[('MAXO:0001298', 'therapy')]	treats			huntington disease	[]	mondo:0007739	huntington disease		[]		anti-sense oligonucleotides		1
29212949			administration	[]	treats			motor coordination issues	[('HP:0011443', 'Coordination issue')]	mondo:0007739	huntington's disease		[]		pridopidine		1
29212949			administration	[]	treats	hp:0000739	anxiety		[]	mondo:0007739	huntington's disease		[]		pridopidine		1
29212949			administration of pridopidine	[]	treats			depressive-like symptoms	[]	mondo:0007739	huntington's disease		[]		pridopidine		1
29212949			administration of pridopidine	[]	treats			striatal transcriptional deficits	[]	mondo:0007739	huntington's disease		[]	with pridopidine	pridopidine		1
33044180			treats	[]	treats			decrease in energy metabolism	[]	mondo:0004975	alzheimer's disease		[]		mitochondrial dysfunction		1
33044180			alpha-ketoglutarate dehydrogenase	[]	treats			decrease in energy metabolism	[]	mondo:0004975	alzheimer's disease		[]		alpha-ketoglutarate dehydrogenase		1
30616867			tetrabenazine administration	[]	treats	hp:0002072	chorea		[]	mondo:0007739	huntington's disease		[]	with tetrabenazine	chebi:9467		1
30616867			deutetrabenazine administration	[]	treats	hp:0002072	chorea		[]	mondo:0007739	huntington's disease		[]	with deutetrabenazine	deutetrabenazine		1
30616867			huntingtin-lowering strategies	[]	target			mutation	[]	mondo:0007739	huntington's disease		[]	with antisense oligonucleotides	chebi:76720		1
30616867			use of antisense oligonucleotides	[]	reduces			levels of huntingtin protein	[]	mondo:0007739	huntington's disease		[]	with antisense oligonucleotides	chebi:76720	mutated	1
30616867			clinical trials exploring motor disability	[]	treats			motor disability	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]				1
30616867			clinical trials	[]	treats	hp:0000737	irritability		[]	mondo:0007739	huntington's disease		[]	exploring irritability			1
30616867			clinical trials	[]	treat			apathy	[('HP:0000741', 'Apathy')]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]	exploring	apathy		1
31745548			intrastriatal administration	[]	treats			huntington disease	[]				[]		aav5-mihtt		1
31745548			intrastriatal administration	[]	treats	hp:0002446	astrogliosis		[]	mondo:0007739	huntington disease		[]	with aav5-mihtt	aav5-mihtt		1
31745548			intrastriatal administration	[]	prevents			cognitive function decline	[]	mondo:0007739	huntington disease		[]	with aav5-mihtt	aav5-mihtt		1
31745548			intrastriatal administration	[]	causes			impairment of motor coordination	[]	mondo:0007739	huntington disease		[]	with aav5-mihtt	aav5-mihtt		1
31745548			intrastriatal administration of aav5-mihtt	[]	causes			striatal atrophy	[]	mondo:0007739	huntington disease		[]	with aav5-mihtt	aav5-mihtt		1
30932891			mri imaging	[]	treats			gray matter atrophy	[]	mondo:0007739	huntington's disease		[]				1
30932891			mri imaging	[]	treats			prodromal white matter degradation	[]	mondo:0007739	huntington's disease		[]				1
30932891			source-based morphometry	[]	treats			gray matter atrophy	[]	mondo:0007739	huntington's disease		[]				1
30932891			source-based morphometry	[]	treats			white matter degradation	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		source-based morphometry	prodromal	1
30932891			independent component analysis	[]	treats			gray matter atrophy	[]	mondo:0007739	huntington's disease		[]				1
30932891			independent component analysis	[]	treats			prodromal white matter degradation	[]	mondo:0007739	huntington's disease		[]				1
30932891			linear mixed model analyses	[]	treats			gray matter atrophy	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		linear mixed model analyses		1
30932891			linear mixed model analyses	[]	treats			prodromal white matter degradation	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]	none	none	none	1
30932891			linear mixed model analyses	[]	treats			motor functioning decline	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		linear mixed model analyses		1
30932891			linear mixed model analyses	[]	treats			cognitive decline	[('HP:0001268', 'Cognitive decline')]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		linear mixed model analyses		1
31724237			responsiveness evaluation of hdqlife and neuro-qol measures	[]	treats			severe motor symptoms	[('HP:0012828', 'Severe'), ('HP:0012828', 'Severe')]	mondo:0007739	huntington disease		[]				1
31724237			responsiveness evaluation	[]	treats			chorea	[('HP:0002072', 'Chorea')]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"		hdqlife and neuro-qol measures		1
31724237			responsiveness evaluation	[]	treats			swallowing difficulties	[('HP:0002015', 'Swallowing difficulties')]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"		hdqlife and neuro-qol measures		1
31724237			responsiveness evaluation of hdqlife and neuro-qol measures	[]	treats	hp:0000750	speech difficulties		[]	mondo:0007739	huntington disease		[]				1
31724237			responsiveness evaluation	[]	treats			upper extremity function difficulties	[]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"		hdqlife and neuro-qol measures		1
31724237			responsiveness evaluation of hdqlife and neuro-qol measures	[]	treats			lower extremity function difficulties	[]	mondo:0007739	huntington disease		[]				1
33795375	maxo:0000137	pet scan		[]	assesses			increased microglial activation	[('HP:0001658', 'MI')]	mondo:0007739	huntington disease		[]		[11c]-er176		1
33795375			mri for anatomic localization	[]	assesses			reduced volumes	[]	mondo:0007739	huntington disease		[]				1
33795375			evaluation of microglial activation	[]	assesses			cumulative disease burden	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		[11c]-er176		1
33918672			partial nej/dcbp depletion	[]	treats			reduced lifespan	[]	mondo:0007739	huntington disease		[]				1
33918672			partial nej/dcbp depletion	[]	treats			impaired locomotor activity	[]	mondo:0007739	huntington disease		[]				1
33918672			foxo-dependent pathway involvement	[]	treats			progressive and fatal autosomal dominant neurodegenerative disease	[('HP:0000006', 'Autosomal dominant'), ('HP:0002180', 'Neurodegenerative disease')]	mondo:0007739	huntington disease		[]				1
38394831			gene editing	[]	treats			dysfunctional mutations	[]			pediatric neurological disorders	[('MONDO:0000001', 'disorder'), ('MONDO:0000001', 'disorders')]		gene editing		1
38394831			crispr-based approaches	[]	treats			dysfunctional mutations	[]			pediatric neurological disorders	[('MONDO:0000001', 'disorder'), ('MONDO:0000001', 'disorders')]		crispr-based approaches	dysfunctional mutations	1
38394831			mutation-specific treatments	[]	treats			dysfunctional mutations	[]			pediatric neurological disorders	[('MONDO:0000001', 'disorder'), ('MONDO:0000001', 'disorders')]		mutation-specific treatments		1
38394831			altering gene expression	[]	treats			dysfunctional mutations	[]			pediatric neurological disorders	[('MONDO:0000001', 'disorder'), ('MONDO:0000001', 'disorders')]		gene expression		1
34330748			activation	[]	prevents			progressive motor impairments	[('HP:0003676', 'Progressive')]	mondo:0007739	huntington disease		[]		metabotropic glutamate receptors 2 and 3		1
34330748			treatment with ly379268	[]	treats			limb coordination and locomotor function impairments	[]	mondo:0007739	huntington disease		[]	with ly379268	chebi:192545		1
34330748			treatment	[]	reduces			mutant huntingtin aggregate formation	[]	mondo:0007739	huntington disease		[]	with ly379268	chebi:192545		1
34330748			treatment	[]	reduces			neuronal cell death	[]	mondo:0007739	huntington disease		[]	with ly379268	chebi:192545		1
34330748			treatment	[]	reduces			microglial activation	[('HP:0001658', 'MI')]	mondo:0007739	huntington disease		[]	with ly379268	chebi:192545		1
34330748			activation of glycogen synthase kinase 3beta-dependent autophagy pathway	[]	treats			mutant huntingtin aggregate formation	[]	mondo:0007739	huntington disease		[]	with ly379268	chebi:192545		1
34330748			reducing akt and erk1/2 phosphorylation	[]	treats			cell signaling abnormalities	[]	mondo:0007739	huntington disease		[]	with ly379268	chebi:192545		1
34330748			increasing akt and erk1/2 phosphorylation	[]	treats			cell signaling abnormalities	[]	mondo:0007739	huntington disease		[]	with ly379268	chebi:192545		1
31720865			rhythmic auditory stimulation	[]	treats			gait impairment	[]	mondo:0008199	<parkinson's disease (pd); huntington disease (hd)>		[]		rhythmic auditory stimulation		1
31720865			rhythmic auditory stimulation	[]	treats			gait freezing	[]	mondo:0008199	<parkinson's disease (pd); huntington disease (hd)>		[]				1
31720865			rhythmic auditory stimulation	[]	prevents	hp:0002527	falls		[]	mondo:0008199	<parkinson's disease (pd); huntington disease (hd)>		[]				1
31720865			group dancing	[]	treats			motor symptoms	[]	mondo:0008199	<parkinson's disease (pd); huntington disease (hd)>		[]				1
31720865			group dancing	[]	treats			non-motor symptoms	[]	mondo:0008199	<parkinson's disease (pd); huntington disease (hd)>		[]				1
31720865			singing	[]	treats			motor symptoms	[]	mondo:0008199	<parkinson's disease (pd); huntington disease (hd)>		[]				1
31720865			singing	[]	treats			non-motor symptoms	[]	mondo:0008199	<parkinson's disease (pd); huntington disease (hd)>		[]				1
31720865			instrumental music performance	[]	treats			motor symptoms	[]	mondo:0008199	<parkinson's disease (pd); huntington disease (hd)>		[]		instrumental music		1
31720865			instrumental music performance	[]	treats			non-motor symptoms	[]	mondo:0008199	<parkinson's disease (pd); huntington disease (hd)>		[]				1
32796930			htt-lowering antisense oligonucleotide administration	[]	treats			toxic mhtt rna	[]	mondo:0007739	huntington disease		[]	with antisense oligonucleotide	chebi:76720		1
32796930			modulation	[]	treats			somatic cag repeat expansion	[]	mondo:0007739	huntington disease		[]		dna repair		1
32796930			targeting the dna mutation	[]	treats			disruption in transcription	[]	mondo:0007739	huntington disease		[]				1
32796930			targeting	[]	treats			interference with immune and mitochondrial function	[('HP:0001427', 'Mitochondrial'), ('HP:0001427', 'mitochondrial')]	mondo:0007739	huntington disease		[]		dna mutation	interference with immune and mitochondrial function	1
32796930			targeting	[]	treats			aberrant post-translational modification of mhtt	[]	mondo:0007739	huntington disease		[]		dna mutation		1
29323618			identify vulnerabilities	[]	treats			anxious attitudes concerning the dying process	[]			palliative care	[('MONDO:0004992', 'CA'), ('MONDO:0011404', 'Car')]		measurement tools		1
29323618			measurement tools identify	[]	treats			anxious attitudes concerning the dying process	[]			palliative care	[('MONDO:0004992', 'CA'), ('MONDO:0011404', 'Car')]		resources	anxious attitudes	1
29323618			subsequent treatment	[]	treats			anxious attitudes concerning the dying process	[]			palliative care	[('MONDO:0004992', 'CA'), ('MONDO:0011404', 'Car')]		measurement tools		1
29323618			relieve suffering	[]	treats			suffering	[]			palliative care	[('MONDO:0004992', 'CA'), ('MONDO:0011404', 'Car')]				1
29323618			support well-being	[]	prevents			suffering	[]			palliative care	[('MONDO:0004992', 'CA'), ('MONDO:0011404', 'Car')]				1
29660633			posturography assessment	[]	treats			deficits in posture	[]	mondo:0007739	huntington's disease		[]				1
29660633			gaitrite assessment	[]	treats			gait alterations	[]	mondo:0007739	huntington's disease		[]				1
29926145			magnetic resonance imaging morphometric analysis	[]	treats	hp:0001272	cerebellar atrophy		[]	mondo:0016621	juvenile huntington disease		[]				1
29926145			automatic segmentation	[]	treats	hp:0001272	cerebellar atrophy		[]	mondo:0016621	juvenile huntington disease		[]		mri images		1
29926145			magnetic resonance imaging morphometric analysis	[]	treats			reduction in size of caudate nucleus, putamen, and globus pallidus	[]	mondo:0016621	juvenile huntington disease		[]				1
29926145			magnetic resonance imaging morphometric analysis	[]	treats			reduction in size of cerebellum lobules, cerebellum grey matter, and cerebellum cortex	[]	mondo:0016621	juvenile huntington disease		[]				1
31356291			differentiating chorea from other movement disorders	[]	prevents			misdiagnosis	[('HP:0001658', 'MI')]	mondo:0001595	chorea		[]				1
31356291			diagnostic approach	[]	treats			misdiagnosis	[('HP:0001658', 'MI')]	mondo:0001595	chorea		[]				1
31356291			immunotherapies	[]	treats	hp:0002072	chorea		[]			c9orf72 disease	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]				1
31356291	maxo:0000943	deep brain stimulation		[]	treats	hp:0002072	chorea		[]			choreic disorders	[('MONDO:0000001', 'disorder'), ('MONDO:0000001', 'disorders')]				1
31356291			genetic interventions	[]	treats	hp:0002072	chorea		[]	mondo:0007739	huntington's disease		[]				1
31356291			new-generation presynaptic dopamine-depleting agents	[]	treats	hp:0002072	chorea		[]				[]		presynaptic dopamine-depleting agents	nkx2-1, adcy5, gnao1, pde10a	1
31208073			intranasal administration	[]	treats			abnormal dopamine transmission system	[]	mondo:0007739	huntington's disease		[]		mesenchymal stem cells (mscs)		1
31208073			intranasal administration	[]	treats			inflammatory reaction	[]	mondo:0007739	huntington's disease		[]		mesenchymal stem cells (mscs)		1
31208073			intranasal administration	[]	prevents			circadian activity disruption	[]	mondo:0007739	huntington's disease		[]		mesenchymal stem cells		1
31208073			intranasal administration of mesenchymal stem cells	[]	improves			decreased survival rate	[('HP:0001370', 'RA')]	mondo:0007739	huntington's disease		[]	intranasally administered	mesenchymal stem cells (mscs)		1
31208073			intranasal administration	[]	treats			decreased iba1 expression	[]	mondo:0007739	huntington's disease		[]		mesenchymal stem cells (mscs)		1
31208073			intranasal administration	[]	treats			altered microglial morphology	[('HP:0001658', 'MI')]	mondo:0007739	huntington's disease		[]		mesenchymal stem cells (mscs)		1
33703929			huntington disease	[]	prevents	hp:0005305	cerebral venous thrombosis		[]				[]				1
33703929			huntington disease	[]	prevents	hp:0001891	iron-deficiency anemia		[]				[]				1
33703929			huntington disease	[]	prevents	hp:0001875	neutropenia		[]				[]				1
31604813			silhouette-length-scaled gait analysis	[]	treats			motor functional differences	[]	mondo:0007739	huntington's disease		[]				1
31604813			silhouette-length-scaled gait analysis	[]	treats			motor functional differences	[]			parkinson's disease	"[('MONDO:0000001', ""Parkinson's disease""), ('MONDO:0000001', 'disease')]"				1
33130907			eye-movement tracking	[]	treats			abnormal visual scanning	[]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"				1
33130907			"""reading the mind in the eyes"" test"	[]	treats			impaired mental state recognition	[]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"	revised	na	na	1
37379724			genetic screening	[]	treats			huntington disease phenocopies	[]			huntington disease phenocopies	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]				1
37379724			targeted genetic analysis	[('MAXO:0000127', 'genetic analysis')]	treats			huntington disease phenocopies	[]			huntington disease phenocopies	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]	targeted	genetic analysis		1
37379724			wes	[('MAXO:0009004', 'WES')]	treats			huntington disease phenocopies	[]			huntington disease phenocopies	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]	na	na	na	1
33658662			generation of hipscs	[]	treats	hp:0002180	neurodegeneration		[]				[]				1
33658662			biological and multi-omics studies	[]	prevents	hp:0002180	neurodegeneration		[]				[]				1
33658662			large-scale screening	[]	treats	hp:0002180	neurodegeneration		[]				[]		chemical libraries		1
33658662			correlation and integration of in vitro experimental data with longitudinal clinical data	[]	prevents	hp:0002180	neurodegeneration		[]				[]				1
31371571			mri	[]	treats			abnormal brain development	[]	mondo:0007739	huntington's disease		[]				1
31371571	maxo:0000127	genetic testing		[]	treats			abnormal brain development	[]	mondo:0007739	huntington's disease		[]				1
31371571			preventative gene silencing therapies	[]	prevents			abnormal brain development	[]	mondo:0007739	huntington's disease		[]		gene silencing therapies		1
35626701			intravenous infusion	[('MAXO:0000757', 'infusion')]	treats			motor disturbances	[]	mondo:0007739	huntington disease		[]		human immature dental pulp stem cells		1
35626701			intravenous infusion	[('MAXO:0000757', 'infusion')]	treats			neuropsychiatric disturbances	[]	mondo:0007739	huntington disease		[]		human immature dental pulp stem cells		1
35626701			intravenous infusion	[('MAXO:0000757', 'infusion')]	treats	hp:0100543	cognitive impairment		[]	mondo:0007739	huntington disease		[]		human immature dental pulp stem cells		1
36242718			treatment	[]	treats	hp:0002072	chorea		[]	mondo:0007739	huntington disease		[]		deutetrabenazine		1
36242718			evaluation of changes in the unified huntington's disease rating scale total motor score and total maximal chorea score	[]	treats			motor symptoms	[]	mondo:0007739	huntington disease		[]				1
36242718			calculation of exposure-adjusted incidence rates for adverse events	[]	prevents			adverse events	[]	mondo:0007739	huntington disease		[]				1
36854393	maxo:0000127	genetic testing		[]	treats	hp:0100022	movement disorders		[]	mondo:0005180	parkinson disease		[]				1
36854393	maxo:0000127	genetic testing		[]	treats	hp:0100022	movement disorders		[]	mondo:0007739	huntington disease		[]				1
36854393			interpretation of genetic test reports	[]	treats	hp:0100022	movement disorders		[]	mondo:0005180	parkinson disease		[]				1
36854393			interpretation of genetic test reports	[]	treats			movement disorders	[('HP:0100022', 'Movement disorder')]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		genetic test reports		1
30890195			ethyl-epa	[]	treats			progressive brain atrophy	[('HP:0003676', 'Progressive'), ('HP:0012444', 'Brain atrophy')]	mondo:0007739	huntington's disease		[]	with ethyl-eicosapentaenoic acid	ethyl-eicosapentaenoic acid		1
30890195			discontinuation	[]	prevents			progressive brain atrophy	[('HP:0003676', 'Progressive'), ('HP:0012444', 'Brain atrophy')]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		drug		1
30890195			mri studies	[]	treats			progressive brain atrophy	[('HP:0003676', 'Progressive'), ('HP:0012444', 'Brain atrophy')]	mondo:0007739	huntington's disease		[]				1
30890195			systematic review and meta-analysis	[]	prevents			progressive brain atrophy	[('HP:0003676', 'Progressive'), ('HP:0012444', 'Brain atrophy')]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]				1
30890195			randomised clinical trials	[]	prevents			progressive brain atrophy	[('HP:0003676', 'Progressive'), ('HP:0012444', 'Brain atrophy')]	mondo:0007739	huntington's disease		[]				1
30890195			treatment	[]	treats			improvement of motor functions	[]	mondo:0007739	huntington's disease		[]	with ethyl-eicosapentaenoic acid	ethyl-epa		1
30890195			quality effect model meta-analysis	[('MAXO:0000775', 'EFF')]	treats			total motor score and total motor score-4 improvements	[]	mondo:0007739	huntington's disease		[]				1
30890195			quality effect model meta-analysis	[('MAXO:0000775', 'EFF')]	treats			maximal chorea score	[('HP:0002072', 'Chorea')]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		quality effect model meta-analysis		1
30687961			phase contrast mri	[]	treats			altered csf dynamics	[]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"		phase contrast mri	altered csf dynamics	1
30687961			intrathecally delivered compounds	[]	treats			huntington's disease	[]				[]	intrathecally delivered	compounds		1
29496355			cognitive evaluations	[]	treats			lower scores in symbol digit modalities test	[]	mondo:0007739	huntington's disease		[]				1
29496355			arithmetic ability test	[('MAXO:0009028', 'ABI')]	treats			poor performance in arithmetic subtraction task	[]	mondo:0007739	huntington's disease		[]				1
29496355			posturography	[]	treats			increased sway velocity	[]	mondo:0007739	huntington's disease		[]				1
29496355			posturography	[]	treats			increased sway distance	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]				1
29496355			brain 3t-mri	[]	treats			bilateral cortical thinning in occipital and parahippocampal regions	[('HP:0012832', 'Bilateral')]	mondo:0007739	huntington's disease		[]		3t-mri	bilateral cortical thinning in occipital and parahippocampal regions	1
29934407	maxo:0000137	pet scan		[]	treats			cognitive and psychiatric symptoms	[]	mondo:0007739	huntington's disease		[]	with 18f-mk-9470	18f-mk-9470		1
29934407			assessment of motor and cognitive function	[]	prevents			cognitive and psychiatric symptoms	[]	mondo:0007739	huntington's disease		[]				1
29934407			behavioral test battery	[]	prevents			cognitive and psychiatric symptoms	[]	mondo:0007739	huntington's disease		[]				1
29934407			mri	[]	prevents			cognitive and psychiatric symptoms	[]	mondo:0007739	huntington's disease		[]		mri		1
29139332			assisted dying	[]	treats			autonomy and kindness	[]	mondo:0007739	huntington's disease		[]				1
34609495			dose-titration study	[]	treats			motor and phonic tics	[('HP:0100033', 'Tics'), ('HP:0100035', 'Phonic tics')]	mondo:0007661	tourette syndrome		[]	with deutetrabenazine	deutetrabenazine		1
34609495			safety assessment	[]	prevents			treatment-emergent adverse events	[]	mondo:0007661	tourette syndrome		[]				1
29383957			pharmacologic treatment of chorea	[]	treats	hp:0002072	chorea		[]	mondo:0007739	huntington's disease		[]				1
29383957			prescribing tetrabenazine	[]	treats	hp:0002072	chorea		[]	mondo:0007739	huntington's disease		[]	with tetrabenazine	chebi:9467		1
29383957			dose interruptions	[]	prevents			overdose	[]	mondo:0007739	huntington's disease		[]				1
29383957			dose reductions	[]	prevents			overdose	[]	mondo:0007739	huntington's disease		[]				1
29383957			titration of dosages	[]	treats	hp:0002072	chorea		[]	mondo:0007739	huntington's disease		[]				1
32995944			dose administration	[]	treats			huntington disease	[]				[]		pridopidine		1
32995944	maxo:0000137	pet scan		[]	treats			huntington disease	[]				[]	using	[18f] fluspidine and [18f] fallypride	with pridopidine	1
32995944			receptor occupancy analysis by the lassen plot	[]	treats			huntington disease	[]				[]	with pridopidine	pridopidine		1
31701651	maxo:0000127	genetic testing		[]	prevents			presymptomatic	[]	mondo:0007739	huntington's disease		[]				1
31701651			electronic health record (ehr) documentation	[]	treats			confidentiality concerns	[]	mondo:0007739	huntington's disease		[]				1
31701651			confidentiality practices	[]	treats			patient demands	[]	mondo:0007739	huntington's disease		[]				1
31701651			policy development for ehr documentation	[]	prevents			confidentiality concerns	[]	mondo:0007739	huntington's disease		[]				1
35767944			evaluation of motor functions and total functional capacity	[]	treats			elevated sympathetic tonic activity	[]	mondo:0007739	huntington disease		[]				1
35767944			measurement of continuous arterial blood pressure	[('MAXO:0000573', 'ART')]	treats			higher mean arterial pressure	[]	mondo:0007739	huntington disease		[]				1
35767944	maxo:0000490	heart rate measurement		[]	treats	hp:0001649	increased heart rate		[]	mondo:0007739	huntington disease		[]				1
35767944			ecg at rest	[('MAXO:0000900', 'ECG')]	prevents			decreased phasic sympathetic activity	[]	mondo:0007739	huntington disease		[]				1
35767944			heart rate variability analysis	[]	treats			drop in phasic parasympathetic activity	[]	mondo:0007739	huntington disease		[]				1
30028085			measuring conventional and advanced resting ecg indices	[('MAXO:0000900', 'ECG')]	treats			cardiac electrical remodeling	[]	mondo:0007739	huntington's disease		[]				1
30028085			measuring conventional and advanced resting ecg indices	[('MAXO:0000900', 'ECG')]	treats			changes in advanced ecg variables	[]	mondo:0007739	huntington's disease		[]				1
30028085			measuring conventional and advanced resting ecg indices	[('MAXO:0000900', 'ECG')]	treats			increase in qt variability	[]	mondo:0007739	huntington's disease		[]				1
30028085			measuring conventional and advanced resting ecg indices	[('MAXO:0000900', 'ECG')]	treats			standard deviation of normal-to-normal qt intervals	[]	mondo:0007739	huntington's disease		[]				1
30028085			measuring conventional and advanced resting ecg indices	[('MAXO:0000900', 'ECG')]	prevents			temporal inhomogeneity in ventricular repolarization	[]	mondo:0007739	huntington's disease		[]				1
29687215			functional assessment	[]	treats			less ability	[]	mondo:0007739	huntington's disease		[]				1
29687215			independence scale assessments	[]	treats			less independence	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		independence scale assessments		1
29687215			total functional capacity assessments	[]	treats			less ability	[]	mondo:0007739	huntington's disease		[]				1
33757575			overexpression	[]	reduces			accumulation of intracellular aggregates	[]	mondo:0005559	neurodegenerative diseases		[]		sgta		1
37358357			pharmacological inhibition	[]	treats			accumulation of aggregate-prone proteins	[]	mondo:0005559	neurodegenerative disease		[]		pharmacological inhibition of ccr5		1
37358357			genetic inhibition	[]	treats			accumulation of aggregate-prone proteins	[]	mondo:0005559	neurodegenerative disease		[]		genetic inhibition of ccr5		1
30771034			diffusion tensor imaging (dti)	[]	treats			decrease in fractional anisotropy	[]	mondo:0007739	huntington's disease		[]				1
30771034			diffusion tensor imaging	[]	treats			increase in axial diffusion	[('HP:0025287', 'Axial')]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"				1
30771034			diffusion tensor imaging (dti)	[]	treats			increase in radial diffusion	[('HP:0001370', 'RAD'), ('HP:0033567', 'RA')]	mondo:0007739	huntington's disease		[]				1
30771034			continuous time random walk	[]	treats			changes in diffusivity	[]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"		ctrw models		1
30771034			histological analysis	[]	treats			decrease in axonal organization	[]	mondo:0007739	huntington's disease		[]				1
30771034			histological analysis	[]	treats			myelin alterations	[]	mondo:0007739	huntington's disease		[]				1
30771034			histological analysis	[]	treats	hp:0002446	astrogliosis		[]	mondo:0007739	huntington's disease		[]				1
30771034			electron microscopy	[]	treats			ultrastructural changes in degenerating axons	[]	mondo:0007739	huntington's disease		[]				1
30771034			electron microscopy	[]	treats			increase in tortuosity	[]	mondo:0007739	huntington's disease		[]				1
30930170			metabolic reprogramming in astrocytes	[]	treats			low glucose	[]	mondo:0007739	huntington's disease		[]				1
30930170			using fatty acids as an energy source	[]	prevents			ros-induced damage	[]	mondo:0007739	huntington's disease		[]		oxidizing fatty acids		1
34583142			timed up & go (tug)	[]	treats			decrease in gait performance	[]	mondo:0007739	huntington disease		[]				1
34583142			standing (feet together, feet apart and foam surface)	[]	treats			greater increase in standing postural sway	[]	mondo:0007739	huntington disease		[]				1
34583142			seated cognitive performance (stroop, symbol digit modalities test (sdmt), delis-kaplan executive function system (dkefs) sorting test)	[]	treats			impairments in performing dual-tasks	[]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"				1
34583142			recording measures of postural sway and time to complete motor tasks	[]	treats			greater increase in standing postural sway	[]	mondo:0007739	huntington disease		[]		apdm opal sensors		1
34583142			recording measures of postural sway and time to complete motor tasks	[]	treats			decrease in gait performance	[]	mondo:0007739	huntington disease		[]		apdm opal sensors		1
30325816			normalization in f-fdg pet imaging	[]	treats			neurometabolic degeneration	[]	mondo:0007739	huntington's disease		[]		f-fdg pet imaging		1
30325816			selection of reference regions in quantitative imaging	[]	treats			neurometabolic degeneration	[]	mondo:0007739	huntington's disease		[]				1
30325816	maxo:0000943	deep brain stimulation		[]	treats			neurometabolic degeneration	[]	mondo:0007739	huntington's disease		[]				1
31381523			psychiatric evaluations	[]	treats			psychological distress	[]	mondo:0007739	huntington's disease		[]				1
31381523			maintaining confidentiality	[]	prevents			psychological distress	[]	mondo:0007739	huntington's disease		[]				1
31381523			psychiatric evaluations	[]	treats			heightened suicide risk	[]	mondo:0007739	huntington's disease		[]				1
31381523			psychiatric evaluations	[]	treats			new onset depression	[('HP:0000716', 'Depression'), ('HP:0000716', 'Depression')]	mondo:0007739	huntington's disease		[]				1
31381523			psychiatric evaluations	[]	treats	hp:0031589	suicidal ideation		[]	mondo:0007739	huntington's disease		[]				1
34448021			volumetric analyses	[]	treats			smaller fornix volume	[]	mondo:0007739	huntington disease		[]		mri		1
33745925			diet administration	[('MAXO:0000088', 'diet')]	treats			motor failure	[]	mondo:0007739	huntington disease		[]		elderberry		1
33745925			diet administration	[('MAXO:0000088', 'diet')]	treats			muscle incoordination	[('HP:0002311', 'Incoordination'), ('HP:0002311', 'Incoordination')]	mondo:0007739	huntington disease		[]		elderberry		1
33745925			diet administration	[('MAXO:0000088', 'diet')]	prevents			oxidative stress-induced cell death	[('HP:0025464', 'Oxidative stress')]	mondo:0007739	huntington disease		[]		elderberry		1
33745925			diet administration	[('MAXO:0000088', 'diet')]	treats			inflammatory responses	[]	mondo:0007739	huntington disease		[]		elderberry		1
33745925			diet administration	[('MAXO:0000088', 'diet')]	treats	hp:0025464	oxidative stress		[]	mondo:0007739	huntington disease		[]		elderberry	with gsh	1
29155766			intravenous infusion	[('MAXO:0000757', 'infusion')]	treats			disruption of blood-brain barrier (bbb) integrity	[]	mondo:0005559	neurodegenerative disease		[]		fitc-labeled albumin		1
29155766			fluorescence microscopy	[]	treats			bbb leakage	[]			neurodegenerative disease	[('MONDO:0000001', 'neurodegenerative disease'), ('MONDO:0000001', 'neurodegenerative disease')]		fluorescence microscopy		1
29155766			using	[]	treats			accumulation of green fluorescent-albumin in the brain parenchyma	[]	mondo:0005559	neurodegenerative disease		[]		image j processing software		1
29325616			genetic testing	[('MAXO:0000127', 'genetic testing')]	prevents			motor symptoms	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]				1
29325616	maxo:0000127	genetic testing		[]	prevents			psychiatric symptoms	[]	mondo:0007739	huntington's disease		[]				1
29325616	maxo:0000127	genetic testing		[]	prevents			cognitive symptoms	[]	mondo:0007739	huntington's disease		[]				1
32302684			gene expression profiles analysis	[]	treats			kidney transplant rejection	[]				[]		gene expression profiles analysis		1
32302684			weighted gene co-expression network analysis (wgcna)	[]	treats			kidney transplant rejection	[]				[]				1
32302684			spearman rank correlation analysis	[]	treats			kidney transplant rejection	[]				[]				1
32302684			gene functional enrichment analysis	[]	treats			kidney transplant rejection	[]				[]		gene functional enrichment analysis		1
32302684			protein-protein interaction analysis	[]	treats			kidney transplant rejection	[]				[]				1
33106388			mri scans	[]	prevents			dilated pvs	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		mri scans	increased	1
33106388			fractional logistic regression analysis	[]	prevents			increased dilated pvs	[]	mondo:0007739	huntington disease		[]				1
33106388			treatment	[]	treats			increased dilated pvs	[]	mondo:0007739	huntington disease		[]	with antisense oligonucleotides	chebi:76720		1
30090698			diffusion tractography procedures	[]	prevents			spatial and temporally defined myelin and axonal degeneration	[('HP:0040078', 'Axonal degeneration')]	mondo:0007739	huntington's disease		[]				1
30090698			neuropsychological tests	[]	treats			impaired performance on neuropsychological tests	[]	mondo:0007739	huntington's disease		[]	none	none	none	1
29335600			spectral phasor analysis	[('MAXO:0009070', 'SPECT')]	treats			alteration in fluidity of cell plasma membrane	[]	mondo:0007739	huntington's disease		[]		spectral phasor analysis		1
29335600			hyperspectral imaging	[]	treats			alteration in fluidity of cell plasma membrane	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		hyperspectral imaging		1
29335600			fluorescence characterization	[]	treats			alteration in fluidity of cell plasma membrane	[]	mondo:0007739	huntington's disease		[]		fluorescence characterization		1
29335600			spectral phasor analysis	[('MAXO:0009070', 'SPECT')]	treats			alteration in fluidity of cell plasma membrane	[]	mondo:0007739	huntington's disease		[]	with laurdan	laurdan		1
29335600			spectral phasor analysis	[('MAXO:0009070', 'SPECT')]	treats			alteration in fluidity of cell plasma membrane	[]	mondo:0007739	huntington's disease		[]	with nile red	chebi:52169		1
32105364			use of 1 postprocessing pipeline to retrospectively analyze t1-weighted magnetic resonance imaging (mri) scans	[]	prevents			undetected progression	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		1 postprocessing pipeline		1
32105364			simulation of possible treatment effects in disease-affected anatomical regions	[('MAXO:0000775', 'EFF')]	prevents			ineffective treatment planning	[]	mondo:0007739	huntington disease		[]				1
32105364			estimation of statistical power of possible treatment effects for anatomical regions and clinical markers	[('MAXO:0000775', 'EFF')]	prevents			underpowered clinical trials	[]	mondo:0007739	huntington disease		[]				1
31778841			multidisciplinary rehabilitation	[]	treats			sleep outcomes	[('HP:0002725', 'SLE')]			preclinical huntington disease	[('MONDO:0000001', 'disease'), ('MONDO:0000001', 'disease')]				1
30008740			gait classification	[]	treats			gait rhythm distortion	[]	mondo:0005559	neurodegenerative disease		[]				1
30008740			utilize symbolic aggregate approximation algorithm	[]	prevents			misclassification	[('HP:0001658', 'MI')]	mondo:0005559	neurodegenerative disease		[]		symbolic aggregate approximation algorithm		1
30008740			testing process using fuzzy k-nearest neighbor	[]	prevents			misclassification	[('HP:0001658', 'MI')]	mondo:0005559	neurodegenerative disease		[]				1
30008740			implement system for classification of als, hd, pd against healthy patients	[]	prevents			misclassification	[('HP:0001658', 'MI')]	mondo:0005559	neurodegenerative disease		[]				1
37855949			electroretinography	[]	treats			clinical manifestations of neurodegenerative diseases	[('HP:0002180', 'Neurodegenerative disease')]	mondo:0005559	neurodegenerative disease		[]				1
37855949	maxo:0000969	optical coherence tomography (oct)		[]	treats			clinical manifestations of neurodegenerative diseases	[('HP:0002180', 'Neurodegenerative disease')]	mondo:0005559	neurodegenerative disease		[]				1
37855949			confocal scanning laser ophthalmoscopy	[]	treats			clinical manifestations of neurodegenerative diseases	[('HP:0002180', 'Neurodegenerative disease')]			neurodegenerative disease	[('MONDO:0000001', 'neurodegenerative disease'), ('MONDO:0000001', 'neurodegenerative disease')]		confocal scanning laser ophthalmoscopy		1
37855949			fluorescence lifetime imaging ophthalmoscopy	[]	treats			clinical manifestations of neurodegenerative diseases	[('HP:0002180', 'Neurodegenerative disease')]	mondo:0005559	neurodegenerative disease		[]				1
37855949			oct angiography	[('MAXO:0000969', 'angiography'), ('MAXO:0001259', 'OCT')]	treats			clinical manifestations of neurodegenerative diseases	[('HP:0002180', 'Neurodegenerative disease')]	mondo:0005559	neurodegenerative disease		[]				1
37855949			use of artificial intelligence techniques	[('MAXO:0000573', 'ART')]	treats			clinical manifestations of neurodegenerative diseases	[('HP:0002180', 'Neurodegenerative disease')]	mondo:0005559	neurodegenerative disease		[]		artificial intelligence techniques		1
37855949			eye-tracking technology	[]	treats			clinical manifestations of neurodegenerative diseases	[('HP:0002180', 'Neurodegenerative disease')]	mondo:0005559	neurodegenerative disease		[]				1
32302555			cell replacement	[]	treats			progressive neuronal loss	[('HP:0002529', 'Neuronal loss'), ('HP:0003676', 'Progressive')]	mondo:0007739	huntington disease		[]	using	human embryonic stem cells		1
32302555			cell replacement	[]	treats			disruption of cortical and basal ganglia circuits	[]	mondo:0007739	huntington disease		[]		human embryonic stem cells		1
32302555			intra-striatal transplantation	[('MAXO:0000068', 'transplantation')]	treats			sensorimotor deficit	[]	mondo:0007739	huntington disease		[]				1
32302555			graft-specific immunohistochemistry	[]	treats			progressive neuronal loss	[('HP:0002529', 'Neuronal loss'), ('HP:0003676', 'Progressive')]	mondo:0007739	huntington disease		[]				1
32302555			rabies virus-mediated synaptic tracing	[]	treats			progressive neuronal loss	[('HP:0002529', 'Neuronal loss'), ('HP:0003676', 'Progressive')]	mondo:0007739	huntington disease		[]		rabies virus-mediated synaptic tracing		1
32302555			ex vivo electrophysiology	[]	treats			progressive neuronal loss	[('HP:0002529', 'Neuronal loss'), ('HP:0003676', 'Progressive')]	mondo:0007739	huntington disease		[]				1
31330407			mri scans	[]	treats			motor dysfunction	[]	mondo:0007739	huntington's disease		[]				1
31330407			mri scans	[]	treats	hp:0100543	cognitive deficits		[]	mondo:0007739	huntington's disease		[]		mri scans		1
31330407			manual segmentation	[]	treats			motor dysfunction	[]	mondo:0007739	huntington's disease		[]				1
31330407			manual segmentation	[]	treats	hp:0100543	cognitive deficits		[]	mondo:0007739	huntington's disease		[]				1
31330407			surface-based parametric mapping	[]	treats			motor dysfunction	[]	mondo:0007739	huntington's disease		[]				1
31330407			surface-based parametric mapping	[]	treats	hp:0100543	cognitive deficits		[]	mondo:0007739	huntington's disease		[]				1
33299145			genetic testing	[('MAXO:0000127', 'genetic testing')]	treats			risk of being a carrier	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]				1
33299145			prenatal diagnosis	[]	prevents			transmission	[]	mondo:0007739	huntington disease		[]				1
32265233			evaluating functional mri data	[('MAXO:0001000', 'Functional MRI')]	prevents			hyperconnectivity	[]	mondo:0007739	huntington disease		[]				1
32265233			evaluating functional mri data	[('MAXO:0001000', 'Functional MRI')]	prevents			striatal hypertrophy	[]			huntington disease	[('MONDO:0000001', 'Huntington disease'), ('MONDO:0000001', 'Huntington disease')]		functional mri data		1
31416725			application	[]	treats			pediatric neurodegenerative disorders	[]			pediatric neurodegenerative disorders	[('MONDO:0000001', 'disorder'), ('MONDO:0000001', 'disorders')]		molecular neuroimaging using positron emission tomographic techniques		1
31416725			sedation	[]	treats			sedation requirements	[]			pediatric neurodegenerative disorders	[('MONDO:0000001', 'disorder'), ('MONDO:0000001', 'disorders')]				1
31416725			radiation exposure mitigation	[('MAXO:0000014', 'radiation')]	prevents			radiation exposure	[('HP:0001370', 'RAD'), ('HP:0033567', 'RA')]			pediatric neurodegenerative disorders	[('MONDO:0000001', 'disorder'), ('MONDO:0000001', 'disorders')]		radiation exposure mitigation		1
31416725			overcoming access barriers	[]	treats			access issues	[]			pediatric neurodegenerative disorders	[('MONDO:0000001', 'disorder'), ('MONDO:0000001', 'disorders')]				1
28987184	maxo:0000127	genetic testing		[]	treats	hp:0001251	ataxia		[]			trinucleotide repeat disorders	[('MONDO:0000001', 'disorder'), ('MONDO:0000001', 'disorders')]				1
28987184	maxo:0000127	genetic testing		[]	treats	hp:0100022	movement disorders		[]			trinucleotide repeat disorders	[('MONDO:0000001', 'disorder'), ('MONDO:0000001', 'disorders')]				1
28987184	maxo:0000127	genetic testing		[]	treats	hp:0100543	cognitive deficits		[]			trinucleotide repeat disorders	[('MONDO:0000001', 'disorder'), ('MONDO:0000001', 'disorders')]		genetic analysis		1
28987184	maxo:0000127	genetic testing		[]	treats	hp:0000708	behavioral symptoms		[]			trinucleotide repeat disorders	[('MONDO:0000001', 'disorder'), ('MONDO:0000001', 'disorders')]				1
30806337			constructed linear mixed models	[]	treats	hp:0000741	apathy		[]	mondo:0007739	huntington's disease		[]				1
30806337			constructed linear mixed models	[]	treats	hp:0100543	cognitive deficits		[]	mondo:0007739	huntington's disease		[]				1
30806337			constructed linear mixed models	[]	treats			motor impairment	[]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"	not specified	not specified	not specified	1
30806337			constructed linear mixed models	[]	treats			psychiatric abnormalities	[]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"		constructed linear mixed models	psychiatric abnormalities	1
34655092			off-resonance saturation mri method	[]	treats			brain iron accumulation	[]	mondo:0004975	alzheimer's disease		[]		off-resonance saturation mri method		1
34655092			off-resonance saturation mri method	[]	treats			brain iron accumulation	[]	mondo:0007739	huntington disease		[]				1
34655092			off-resonance saturation mri method	[]	treats			brain iron accumulation	[]	mondo:0011426	aceruloplasminemia		[]		off-resonance saturation mri method		1
33852093			advance care planning	[]	prevents			inability to make decisions	[]	mondo:0007739	huntington disease		[]				1
33852093			implanting a feeding tube	[]	treats			inability to eat by oneself	[]	mondo:0007739	huntington disease		[]				1
33852093			performing a tracheostomy	[('MAXO:0000504', 'tracheostomy'), ('MAXO:0000504', 'trach')]	treats	hp:0002093	respiratory insufficiency		[]	mondo:0007739	huntington disease		[]				1
33852093			engaging patients in decision-making	[]	prevents			inability to express will	[]	mondo:0007739	huntington disease		[]				1
31759995			dna damage assessment	[]	treats			neuropsychiatric manifestations	[]	mondo:0007739	huntington disease		[]				1
31759995			oxidative stress measurement	[]	treats			motor manifestations	[]	mondo:0007739	huntington disease		[]		oxidative stress measurement		1
31759995			telomere length analysis	[]	treats			cognitive manifestations	[]	mondo:0007739	huntington disease		[]				1
29282160			social inference task performance assessment	[]	treats			impaired emotion recognition	[]	mondo:0007739	huntington's disease		[]				1
29282160			severity ratings assessment	[]	treats	hp:0000741	apathy		[]	mondo:0007739	huntington's disease		[]				1
29282160			severity ratings assessment	[]	treats			disinhibition	[('HP:0000734', 'Disinhibition')]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"				1
29282160			motor symptom severity evaluation	[]	prevents			relationship breakdown	[]	mondo:0007739	huntington's disease		[]				1
29967967	maxo:0000127	genetic testing		[]	prevents			uncertainty	[]	mondo:0007739	huntington's disease		[]				1
29967967			physician ordering (without formal protocol)	[]	treats			need for genetic information	[]	mondo:0007739	huntington's disease		[]				1
29967967			direct-to-consumer (dtc) genetic testing	[('MAXO:0000127', 'genetic testing')]	treats			need for genetic information	[]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"				1
29967967			returning medically actionable secondary findings	[]	prevents			further health complications	[]	mondo:0007739	huntington's disease		[]				1
33202151			electroacupuncture	[]	treats			motor symptoms	[]	mondo:0005180	parkinson disease		[]				1
33202151			enhancing autophagy	[]	prevents			autophagic defects	[]	mondo:0005180	parkinson disease		[]	with beclin 1	beclin 1		1
33202151			enhancing autophagy	[]	prevents			autophagic defects	[]	mondo:0005180	parkinson disease		[]	with atg5	atg5		1
33202151			enhancing autophagy	[]	prevents			autophagic defects	[]	mondo:0005180	parkinson disease		[]	with atg7	atg7	autophagic defects	1
33202151			enhancing autophagy	[]	prevents			autophagic defects	[]	mondo:0005180	parkinson disease		[]	with atg9a	atg9a		1
33202151			enhancing autophagy	[]	prevents			autophagic defects	[]	mondo:0005180	parkinson disease		[]	with	atg12		1
33202151			enhancing autophagy	[]	prevents			autophagic defects	[]	mondo:0005180	parkinson disease		[]	with atg16l	atg16l		1
33202151			enhancing autophagy	[]	prevents			autophagic defects	[]	mondo:0005180	parkinson disease		[]	with atg3	atg3		1
33202151			enhancing autophagy	[]	prevents			autophagic defects	[]	mondo:0005180	parkinson disease		[]	with lc3-ii	lc3-ii		1
33202151			enhancing autophagy	[]	prevents			autophagic defects	[]	mondo:0005180	parkinson disease		[]	with p62	p62		1
33202151			enhancing autophagy	[]	prevents			autophagic defects	[]	mondo:0005180	parkinson disease		[]	with pink1	pink1		1
33202151			enhancing autophagy	[]	prevents			autophagic defects	[]	mondo:0005180	parkinson disease		[]	with dj-1	dj-1		1
29715545			genetic screening	[]	prevents			misdiagnosis	[('HP:0001658', 'MI')]	mondo:0000863	multiple system atrophy (msa)		[]		polyglutamine disease genes		1
29715545			analysis of triplet repeat length	[]	diagnoses	hp:0012332	autonomic dysfunction		[]	mondo:0000863	multiple system atrophy (msa)		[]				1
29715545			genetic screening	[]	diagnoses			parkinsonism	[('HP:0001300', 'Parkinsonism')]	mondo:0000863	multiple system atrophy (msa)		[]		polyglutamine disease genes		1
29715545			genetic screening	[]	diagnoses			cerebellar ataxia	[('HP:0001251', 'Cerebellar ataxia'), ('HP:0001251', 'Ataxia')]	mondo:0000863	multiple system atrophy (msa)		[]		polyglutamine disease genes		1
37040787			development of antisense oligonucleotides	[]	treats	hp:0002180	neurodegeneration		[]	mondo:0007739	huntington disease		[]		chebi:76720		1
37040787			micro-rnas	[]	treats	hp:0002180	neurodegeneration		[]	mondo:0007739	huntington disease		[]		micro-rnas		1
37040787			modulators of rna processing (splicing)	[]	treats	hp:0002180	neurodegeneration		[]	mondo:0007739	huntington disease		[]		modulators of rna processing (splicing)		1
37040787			zinc finger proteins	[]	treats			neurodegenerative disease	[('HP:0002180', 'Neurodegenerative disease')]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"		zinc finger proteins		1
30631115			dna size analysis	[]	treats			severity of diseases	[('HP:0012824', 'Severity')]			expanded trinucleotide repeat disorders	[('MONDO:0000001', 'disorder'), ('MONDO:0000001', 'disorders')]				1
30631115			detection of heterogeneous allele lengths	[]	treats			severity of diseases	[('HP:0012824', 'Severity')]			expanded trinucleotide repeat disorders	[('MONDO:0000001', 'disorder'), ('MONDO:0000001', 'disorders')]				1
35812247			knockdown	[]	treats			proliferation of crc cells	[]	mondo:0005575	colorectal cancer		[]		nav3		1
35812247			rt-pcr	[('MAXO:0000014', 'RT')]	treats			diagnosis	[]	mondo:0005575	colorectal cancer		[]				1
30468934			body composition assessment	[]	prevents	hp:0001824	weight loss		[]	mondo:0007739	huntington's disease		[]				1
30468934			bone mineral density measurement	[]	prevents	hp:0004349	reduced bone mineral density		[]	mondo:0007739	huntington's disease		[]				1
30468934			dual-energy x-ray absorptiometry	[]	treats	hp:0004349	reduced bone mineral density		[]	mondo:0007739	huntington's disease		[]				1
32479211	maxo:0000016	cell therapy		[]	treats			neurodegenerative disorders	[]				[]				1
32479211	maxo:0000068	transplantation		[]	treats			neurodegenerative disorders	[]				[]		uc-mscs		1
32427942			injection of hyperpolarizing currents into the stn	[]	treats			hyperkinetic behaviors	[]			hyperkinetic movement disorders	[('MONDO:0005395', 'movement disorder'), ('MONDO:0005395', 'movement disorder')]				1
32427942			deep brain stimulation	[('MAXO:0000943', 'deep brain stimulation')]	treats			hyperkinetic behaviors	[]			hyperkinetic movement disorders	[('MONDO:0005395', 'movement disorder'), ('MONDO:0005395', 'movement disorder')]				1
32427942			injection into the stn	[]	treats			hyperkinetic movement disorders	[('HP:0100022', 'Movement disorder')]	mondo:0005180	parkinson disease		[]		depolarizing currents	levodopa	1
31900464			use of oestrogens	[]	treats			motor symptoms	[]	mondo:0005180	parkinson disease		[]		chebi:50114	severity	1
31900464			elevation of androgens	[]	exacerbates	hp:0100033	tic disorders		[]	mondo:0005395	movement disorders		[]		chebi:50113		1
30546084			prenatal diagnosis	[]	treats			late-onset autosomal dominant neurodegenerative disorder	[('HP:0000006', 'Autosomal dominant'), ('HP:0003674', 'Onset')]	mondo:0007739	huntington's disease		[]				1
30546084	maxo:0009003	preimplantation genetic testing (pgt-m)		[]	prevents			late-onset autosomal dominant neurodegenerative disorder	[('HP:0000006', 'Autosomal dominant'), ('HP:0003674', 'Onset')]	mondo:0007739	huntington's disease		[]				1
30546084			informed of all options	[]	prevents			late-onset autosomal dominant neurodegenerative disorder	[('HP:0000006', 'Autosomal dominant'), ('HP:0003674', 'Onset')]	mondo:0007739	huntington's disease		[]				1
34162958			fixel-based analysis (fba)	[]	investigates			white matter damage	[]			huntington's disease	"[('MONDO:0000001', ""Huntington's disease""), ('MONDO:0000001', 'disease')]"		fixel-based analysis (fba)		1
34162958			diffusion-weighted magnetic resonance spectroscopy (dw-mrs)	[('MAXO:0009070', 'SPECT')]	quantifies			alterations to brain microstructure	[('HP:0001658', 'MI')]	mondo:0007739	huntington disease		[]				1
34162958			diffusion-weighted magnetic resonance spectroscopy	[('MAXO:0009070', 'SPECT')]	treats			reduced mean diffusivity of the intra-axonal metabolite n-acetylaspartate in the corpus callosum	[]	mondo:0007739	huntington disease		[]				1
37699467			surface-enhanced raman spectroscopy	[('MAXO:0009070', 'SPECT')]	detects			structural changes	[]			insulin	[]		surface-enhanced raman spectroscopy		1
37699467			chemical reduction method	[]	detects			structural changes	[]			insulin	[]	with silver nanoparticles (ag-nps)	chebi:50826		1
37699467			multivariate discriminating analysis techniques	[]	analyze			decrease in functional efficacy	[]			type-2 diabetes	[('MONDO:0005015', 'diabetes'), ('MONDO:0018849', 'DI')]		insulin	functional efficacy	1
37699467			principal component analysis	[]	detects			structural changes	[]			insulin	[]		chebi:36751		1
37699467			partial least square regression analysis (plsr)	[]	detects			structural changes	[]			insulin	[]		partial least square regression analysis (plsr)		1
